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Table 4-1:  Experimental flow rates measured using the weight determination method.  
The listed flow rates are an averaged value of the fluid collected prior to the 
first scan and after the last scan, with the exception of the two highest flow 
rates for the largest diameter of 11.11 mm. 
 
Table 4-2:  Imaging parameters for the gradient-echo breath-held velocity-encoded 
acquisitions. 
 
Table 4-3:  Experimental flow rates used to assess inter- and intraobserver variability.  
Data was compiled at these flow rates, which represent a mid-range rate of 
flow for each simulated vessel, at 160 and 200 mm FOV (n = 12).   
 
Table 5-1:  Correlation coefficients calculated for each ROI based upon the data 
presented in Figures 5-3 through 5-5.   
 
Table 5-2:  Various quantitative results extracted from the Bland and Altman plots 
shown in Appendix A (Figures A-1 through A-18).  The bias is calculated 
by finding the mean difference between methods, and may be used to adjust 
results obtained using a new clinical method based on a more established 
one.  Based on the assumption of a normal distribution, the majority of data 
points (95%) will lie within two standard deviations (SD) of the mean.  The 
upper and lower percent differences display the difference between methods 
as a percent of the averages.  The terms in the table correspond to the 
following: magnitude image contour (ROI 1); phase image contour (ROI 2); 
and automatic contour (ROI 3).  “BG” denotes that background subtraction 
has been applied to the data series.   
 
Table 5-3:  Various quantitative results extracted from the Bland and Altman plots 
shown in Figures 5-26 through 5-35 using low-resolution protocol (96 phase 
encodings).  A brief description of each of these statistical parameters is 
provided with Table 5-2.  When comparing the values in this table with 
those in Table 5-2, it is apparent that high-resolution protocol (192 phase 
encodings) provides significantly more accurate results, as further shown in 
the following figures. 
 
Table 5-4:  Reynolds numbers resulting from experimental flow rates measured using 
the weight determination method, which are shown in parentheses below 
each corresponding Reynolds number.  The Reynolds numbers listed below 
were calculated using Equation (4-2) and are all within the laminar range, as 







Table 5-5:  Quantitative summary resulting from experiment with velocity encoded in 
three directions.  A field of view of 240 mm was used in this protocol.   The 
magnitude (ROI 1), phase (ROI 2), and automatic (ROI 3) borders were 
analyzed using this technique.  The automatic detection algorithm most 
accurately analyzed the velocity data encoded in the phase-velocity images 
for this protocol, but not by a significant amount. 
 
Table 6-1: Parameters used to correct wraparound artifact for 3.175 mm simulated 
vessel.  Vmin and vmax are provided for each scan corrected.  It is 
important to note the direct relationship between FOV and the degree of 
aliasing:  as the FOV increases, the degree of phase wrap increases, as well. 
 
Table 6-2: Resulting COV values between true flow and flow measured using velocity-
encoded MRI (graphically shown in Figures 5-14 and 5-15).  Background 
subtraction actually increased the COV between the true flow MRI flow in 























Figure 2-1:  Anterior view of kidneys in situ. It is interesting to note that the left kidney 
is usually larger than the right [30-31]. [33] 
 
Figure 2-2:  Kidney anatomy and enhanced view of nephron. [34] 
 
Figure 2-3:  Illustrative comparison of polycystic and normal kidneys. [42] 
 
Figure 2-4:  Comparison of polycystic kidney (left) with a healthy kidney (right). 
 [29] 
 
Figure 4-1: PVA phantom used in validation experiments.  The model was constructed 
with six hollow channels running through the PVA ranging in diameter from 
3.18 to 11.11 (± 0.01) mm.  PVA proved to be the superior choice among 
other possible phantom materials during initial experimentation. 
 
Figure 4-2: The chemical structure of the polyvinyl alcohol molecule.  PVA has been 
reported to have a number of significant medical applications including its 
use in MR quality control phantoms. 
 
Figure 4-3: Flow loop used in steady flow validation experiment.  This schematic shows 
the setup for the 9.53 mm experiment.  It is also important to note that PVC 
tubing was returned over the phantom model in order to capture flow 
through the vinyl (PVC) tubing for comparison of material experiments.  
The same set of PVC tubing would have also been used for the 11.11 mm 
experiments. 
 
Figure 4-4: This diagram displays the two main properties of NMR. (a) In the absence 
of an external magnetic field, a hydrogen proton has an intrinsic magnetic 
field due to the property of nuclear spin.  (b) When an external magnetic 
field (B0) is applied, the spinning proton not only spins about its own axis, 
but also around the axis created by the applied magnetism.   
 
Figure 4-5: (a) A representation of the chaotic array of hydrogen protons when an 
external magnetic field (B0) is absent and (b) the alignment that occurs when 
the magnetic field is applied.  In (b), the bars above and below the protons 
represent the poles of the magnet.  In MRI, protons may either align with the 
direction of the magnetic field or against it, resulting in two different energy 
states.  In this example, when B0 is applied, the first two columns represent 
the lower energy state, as these protons align in the direction of the external 




Figure 4-6: Sample screen layout using the FLOW software package.  The first region  
 of interest (red) was drawn manually in the modulus image (right), while the 
second region of interest (green) was drawn in the phase image (left).  The 
third region of interest (white) was created using the automatic contour 
detection algorithm included in the program.  The fourth region of interest 
(C-shape) was used to correct for static velocity components. 
 
Figure 4-7:  Example of a Bland and Altman Plot using the difference between 
 methods.  Other variations of this plot may be used, including the  
 presentation of the difference between methods as a percent, which will be  
 further discussed in Chapter V. 
 
Figure 5-1: Flow rate data obtained from PVA and plastic at the 200 mm FOV with no 
background correction applied.  These results were obtained from the 
following channels: 3.18, 4.76, and 7.94 mm.  As shown, the plastic data 
deviates more from the true flow rate values than the PVA data. 
 
Figure 5-2: Average COV results calculated from the image data acquired using PVA, 
plastic, and glass at the 200 mm FOV.  The average COV of PVA is 
consistently less than that of the two supplementary materials studied. 
 
Figure 5-3: Flow rate data obtained from high-resolution experiments at the 160 mm 
FOV as compared to the true flow rates calculated using the weight 
determination method.  All flow rates presented here span the entire range of 
simulated vessels (n = 32).  The terms in the legend correspond to the 
following: magnitude image contour (ROI 1); phase image contour (ROI 2); 
and automatic contour (ROI 3).  “BG” denotes that background subtraction 
has been applied to the data series. 
 
Figure 5-4: Flow rate data obtained from high-resolution experiments at the 200 mm 
FOV as compared to the true flow rates calculated using the weight 
determination method.  All flow rates presented here span the entire range of 
simulated vessels (n = 32).  The terms in the legend correspond to the 
following: magnitude image contour (ROI 1); phase image contour (ROI 2); 
and automatic contour (ROI 3).  “BG” denotes that background subtraction 
has been applied to the data series. 
 
Figure 5-5: Flow rate data obtained from high-resolution experiments at the 350 mm 
FOV as compared to the true flow rates calculated using the weight 
determination method.  All flow rates presented here span the entire range of 
simulated vessels (n = 32), except for ROI 3 and BG ROI 3, where n = 31. 
The terms in the legend correspond to the following: magnitude image 
contour (ROI 1); phase image contour (ROI 2); and automatic contour (ROI 
3).  “BG” denotes that background subtraction has been applied to the data 
series.   
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Figure 5-6: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the magnitude border (ROI 1) at 
160, 200, and 350 mm FOV and corresponds to the data presented in Table 
5-2.  The 160 mm FOV proved to be the most accurate parameter in this 
case, while the 350 mm FOV was the least accurate. 
 
Figure 5-7: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the phase border (ROI 2) at 160, 
200, and 350 mm FOV and corresponds to the data presented in Table 5-2.  
The 200 mm FOV proved to be the most accurate parameter in this case, 
while the 350 mm FOV was the least accurate. 
 
Figure 5-8: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the automatic border (ROI 3) at 160, 
200, and 350 mm FOV and corresponds to the data presented in Table 5-2.  
The 200 mm FOV proved to be the most accurate parameter in this case, 
while the 350 mm FOV was once again the least accurate. 
 
Figure 5-9: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the magnitude border with 
background correction (BG ROI 1) at 160, 200, and 350 mm FOV and 
corresponds to the data presented in Table 5-2.  The 160 mm FOV proved to 
be the most accurate parameter in this case, while the 200 mm FOV was the 
least accurate. 
 
Figure 5-10: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the phase border with background 
correction (BG ROI 2) at 160, 200, and 350 mm FOV and corresponds to 
the data presented in Table 5-2.  In this case, the 160 and 200 mm FOV 
were the most accurate parameters. 
 
Figure 5-11: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the automatic border with 
background correction (BG ROI 1) at 160, 200, and 350 mm FOV and 
corresponds to the data presented in Table 5-2.  The 200 mm FOV proved to 
be the most accurate parameter in this case, while the 350 mm FOV was the 
least accurate. 
 
Figure 5-12: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 64).  This plot corresponds to 
combined data sets of ROI 1 and ROI 2 at the 160 mm FOV.   
 
Figure 5-13: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 64).  This plot corresponds to 
combined data sets of ROI 1 and ROI 2 at the 200 mm FOV.   
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Figure 5-14: Average COV results calculated from the image data acquired using the 160 
mm FOV.  Background correction (BG) does not improve the results and 
even has a significant negative effect on ROI 1 and ROI 3. 
 
Figure 5-15: Average COV results calculated from the image data acquired using the 200 
mm FOV.  Background correction (BG) has no positive effect on this data, 
as all ROIs are negatively affected and vary more from true flow. 
 
Figure 5-16: Graphical comparison of high-resolution (192 phase encodings) and low-
resolution (96 phase encodings) protocol obtained using the Bland-Altman 
method.  The data presented here was acquired using the magnitude border 
(ROI 1) at the 160, 200, and 350 mm FOV and corresponds to the data 
presented in Table 5-3.  The amount of variability between low- and high-
resolution increased with increasing field of view. 
 
Figure 5-17: Graphical comparison of high-resolution (192 phase encodings) and low-
resolution (96 phase encodings) protocol obtained using the Bland-Altman 
method.  The data presented here was acquired using the phase border (ROI 
2) at the 160, 200, and 350 mm FOV and corresponds to the data presented 
in Table 5-3.  The amount of variability between low- and high-resolution 
again increased with increasing field of view. 
 
Figure 5-18: Graphical comparison of high-resolution (192 phase encodings) and low-
resolution (96 phase encodings) protocol obtained using the Bland-Altman 
method.  The data presented here was acquired using the automatic border 
(ROI 3) at 160, 200, and 350 mm FOV and corresponds to the data 
presented in Table 5-3.  In this case, the low-resolution data is comparable at 
160 and 200 mm FOV, while increased variability is observed at 350 mm 
FOV. 
 
Figure 5-19: Bland and Altman plot displaying the difference between true flow values 
and MRI data as a percentage using low-resolution protocol (96 phase 
encodings).  This figure specifically shows the extreme deviation from true 
flow, especially at lower flow rates (< 500 ml/min).  Data presented here is 
from the phase image contour obtained using 160 mm FOV.   
 
Figure 5-20: Bland and Altman plot displaying the difference between true flow values 
and MRI data as a percentage using low-resolution protocol (96 phase 
encodings).  This figure also shows the extreme deviation from true flow, 
specifically at lower flow rates (< 500 ml/min).  Data presented here is from 






Figure 5-21: Schematic showing visually-defined perpendicular planes used to capture 
velocity-encoded phase images in this phantom validation study.  The first 
scan plane is centered along the phantom, and this data is presented as the 
200 mm FOV high-resolution data.  The second and third scan planes were 
used to evaluate flow along the length of each simulated vessel at the 200 
mm FOV. 
 
Figure 5-22: Bland and Altman plot displaying the difference between sites 2 and 3 as 
compared to site 1 (Figure 5-21).  This plot corresponds to the manual 
contour drawn in the magnitude image (ROI 1) at the 200 mm FOV. 
 
Figure 5-23: Bland and Altman plot displaying the difference between sites 2 and 3 as 
compared to site 1 (Figure 5-21).  This plot corresponds to the manual 
contour drawn in the phase image (ROI 2) at the 200 mm FOV. 
 
Figure 5-24: Graphical comparison of high-resolution protocol at the 200 mm FOV with 
protocol velocity-encoded in all three orthogonal planes (240 mm FOV).  It 
is shown that this technique is not useful as compared to high-resolution 
protocol, as increased variability is observed with all image contours at the 
240 mm FOV. 
 
Figure 6-1: In vitro and in vivo breath-held phase-velocity encoded MRI scans.  The 
plastic material in (A) was found to perform less like the in vivo tissue in (B) 
than the PVA in (C). 
 
Figure 6-2: Comparison of Bland-Altman plots using the phase border using (A) the 160 
mm FOV and (B) the 350 mm FOV.  The 95% limits of agreement for the  
350 mm FOV data were larger than the 160 mm FOV, indicating that 
minimization of FOV is important for accurate flow results. 
 
Figure 6-3: Phase image for the 160 mm FOV scan obtained for the 3.18 mm channel 
experiment.  The arrow points to the flow region, which contains the 
wraparound artifact.  This phenomenon is due to the excitation of tissue 
outside the defined FOV boundary, which causes the anatomy to be 
displaced from its actual position.  This image was corrected by properly 
encoding the “unwanted” tissue using the phase-unwrap feature in the 
FLOW software program.  These values are presented in Table 6-1. 
 
Figure A-1: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) without background 





Figure A-2: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) with background correction 
at 160 mm FOV.   
 
 
Figure A-3: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) without background correction at 
160 mm FOV.   
 
Figure A-4: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) with background correction at 
160 mm FOV.   
Figure A-5: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 
the FLOW software without background correction at 160 mm FOV.   
 
Figure A-6: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 
the FLOW software with background correction at 160 mm FOV.   
 
Figure A-7: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) without background 
correction at 200 mm FOV.   
 
Figure A-8: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) with background correction 
at 200 mm FOV.   
 
Figure A-9: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) without background correction at 
200 mm FOV.   
 
Figure A-10: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) with background correction at 
200 mm FOV.   
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Figure A-11: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 
the FLOW software without background correction at 200 mm FOV.   
 
Figure A-12: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 
the FLOW software with background correction at 200 mm FOV.   
 
Figure A-13: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) without background 
correction at 350 mm FOV.   
 
Figure A-14: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) with background correction 
at 350 mm FOV.   
 
Figure A-15: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) without background correction at 
350 mm FOV.   
 
Figure A-16: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) with background correction at 
350 mm FOV.   
 
Figure A-17: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 31).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 
the FLOW software without background correction at 350 mm FOV.   
 
Figure A-18: Bland and Altman plot displaying the difference between the true flow  
 values and the experimental MRI data (n = 31).  This plot corresponds to the  
automatic contour drawn in the phase image (ROI 3) using the algorithm in 
the FLOW software with background correction at 350 mm FOV.   
 
Figure A-19: Bland and Altman plot displaying the difference between methods using two 




Figure A-20: Bland and Altman plot displaying the difference between methods using two 
independent and blinded observers at the 200 mm FOV (interobserver 
study). 
 
Figure A-21: Bland and Altman plot displaying the difference between methods using a 
single observer at two different dates at the 160 mm FOV (intraobserver 
study). 
 
Figure A-22: Bland and Altman plot displaying the difference between methods using a 
single observer at two different dates at the 200 mm FOV (intraobserver 
study). 
 
Figure A-23: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the magnitude image 
(ROI 1) at 160 mm FOV.   
 
Figure A-24: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the phase image (ROI 2) 
at 160 mm FOV.   
 
Figure A-25: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the automatic contour drawn in the phase 
image (ROI 3) using the algorithm in the FLOW software at 160 mm FOV.   
 
Figure A-26: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the magnitude image 
(ROI 1) at 200 mm FOV.   
 
Figure A-27: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the phase image (ROI 2) 
at 200 mm FOV.   
 
Figure A-28: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the automatic contour drawn in the phase 
image (ROI 3) using the algorithm in the FLOW software at 200 mm FOV.   
 
Figure A-29: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the magnitude image 
(ROI 1) at 350 mm FOV.   
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Figure A-30: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the phase image (ROI 2) 
at 350 mm FOV.   
 
Figure A-31: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
31).  This plot corresponds to the automatic contour drawn in the phase 























ADPKD (autosomal polycystic kidney disease) 
RBF (renal blood flow) 
MRI (magnetic resonance imaging) 
CT (computed tomography) 
NIH (National Institutes of Health) 
CRISP (Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease) 
2D PC MR (two-dimensional phase-contrast magnetic resonance) 
PVA (polyvinyl alcohol) 
GFR (glomerular filtration rate) 
PKD (polycystic kidney disease) 
PAH (para-amino-hippurate, a clearance technique) 
MRA (magnetic resonance angiography) 
NMR (nuclear magnetic resonance) 
RF (radiofrequency) 
PVC MRI (phase-velocity cine MRI) 
FE-EPI (multi-shot echoplanar imaging) 
FOV (field of view) 







Autosomal dominant polycystic disease (ADPKD) is the most common hereditary 
renal disease and is characterized by renal cyst growth and enlargement.  Hypertension 
occurs early when renal function is normal and is characterized by decreased renal blood 
flow.  Accordingly, the measurement of blood flow in the renal arteries can be a valuable 
tool in evaluating disease progression.  In studies performed in conjunction with this 
work, blood flow was measured through the renal arteries using magnetic resonance 
imaging (MRI).  In order to validate these in vivo measurements, a vascular phantom was 
created using polyvinyl alcohol (PVA) and also scanned using MRI under controlled 
steady flow conditions.  Ranges of vessel diameters and flow velocities were used to 
simulate actual flow in a normal and diseased population of adults and children.  
With the vessel diameters studied in this experiment, minimization of field of 
view and an increase in spatial resolution is important in obtaining accurate data.  
However, a significant difference does not exist between the results when using the 160 
or 200 mm FOV.  An increase in the number of phase encodings provides improved 
results, although an increase in image acquisition time is observed.  Velocity-encoding in 
all three orthogonal directions does not improve image data.  This method of using MRI 
to measure flow through a vessel is shown to be both accurate and reproducible, and the 
protocol providing the most correct results is prescribed.   
Breath-hold phase-velocity encoded MRI proves to be an accurate and 
reproducible technique in capturing flow and has the potential to be used for the purpose 
of observing hemodynamic changes in the renal arteries with the progression of ADPKD. 
 xxi
The results of these experiments are currently being implemented and used in patient 
studies to determine the extent to which MRI may be used as a non-invasive diagnostic 









 Autosomal dominant polycystic kidney disease (ADPKD) is the most common 
hereditary renal disease, affecting approximately 500,000 people in the United States, 
alone [1].  Of these, approximately 1,800 require the initiation of renal replacement 
therapy each year [2], costing half-a-billion dollars annually [3].  About 1 in 1,000 
individuals carry a mutant gene causing this condition [4], which is a disease 
distinguished by renal cyst growth and enlargement.  ADPKD is also one of many 
pathologies characterized by decreased renal blood flow (RBF).  Hypertension occurs 
early when renal function is essentially normal, and it is preceded by, or seen in 
conjunction with, compromised flow in the renal arteries [5].  Accordingly, the 
measurement of blood flow in renal arteries may become a valuable tool in evaluating 
disease progression.  Renal sufficiency deteriorates as the disease progresses, ultimately 
resulting in end-stage renal failure.  ADPKD is the single greatest cause of end-stage 
renal failure in the United States, following diabetes mellitus, hypertension, and 
glomerulonephritis [3].                                                                                                                                   
 Little attention has been given to the idea that the evaluation of RBF may be used 
as a marker of disease severity, despite evidence that it may contribute to renal failure.  
Even as early as 1929, it was noticed that the vascular system is impaired in ADPKD 
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individuals.  It has been shown that the number of small arteries and arterioles is greatly 
reduced in polycystic kidneys [6] and that an increased wall-to-lumen ratio exists in these 
vascular areas [7-8].  These observations have been confirmed in more recent studies [9].   
Because approximately ninety-five percent of ADPKD patients inherit the disease 
from a parent [2], an effective early detection and prevention program is essential in an 
effort to care for individuals in this population.  Over the past ten years, major advances 
in the understanding of genetics, as well as the mechanisms and rate of disease 
progression, have continued to provide hope that this type of program will soon become 
available.  A number of modalities have been used to assess this disease, both invasive 
and non-invasive.  Recent technological improvements have improved non-invasive data 
acquisition techniques.  The information that has been obtained using a number of these 
improved modalities has provided additional insight into the pathogenesis of ADPKD.   
Magnetic resonance imaging (MRI) is not the only available non-invasive 
modality used in diagnosing and treating ADPKD; however, other modalities, such as 
ultrasound and computed tomography (CT), do not provide the same range of 
information as MRI.  In one scan session, renal hemodynamic parameters, as well as an 
entire map of kidney and cyst volumes may be obtained.  Ultrasound also causes some 
degree of discomfort, as the probe must be firmly pressed over the ribs to obtain accurate 
images of the left and right kidneys.  Only MRI provides the wide range of diagnostic 
images needed to accurately diagnose and assess the disease. 
With the vast progress that has been made using non-invasive technologies, 
specifically in MRI, the use of RBF measurements for treatment purposes is receiving 
more attention from medical professionals and researchers.  It is becoming an established 
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technique, particularly in the area of cardiology.  Multiple studies have validated its 
accuracy for this purpose in both flow phantoms and in vivo [10-18].  In a multi-center 
National Institutes of Health (NIH)-sponsored study, referred to as the Consortium for 
Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP), an effort was made 
to develop accurate MRI protocol assessing RBF changes in ADPKD patients using 
longitudinal MRI studies.  This clinical study is currently exploring the use of two-
dimensional breath-held gradient echo techniques using existing clinical imaging 
equipment to establish an effective method for accomplishing the aforementioned goal.  
Using one hundred twenty-seven ADPKD subjects, King et al. have studied the changes 
that occur as the disease progresses, including those observed in RBF, as well as total and 
cyst renal volumes, using MRI [19].       
To ensure that this RBF data is valid, a comprehensive vascular phantom 
validation study was performed using a full range of vessel diameters and flow rates 
testing the physiological ranges of flow and arterial sizes encountered in vivo.        
In this study, a series of two-dimensional phase-contrast magnetic resonance (2D PC 
MR) scans was performed on a range of simulated vessels representing both normal and 
diseased flow.  The resulting data was analyzed in order to extract the flow measurements 
recorded using the velocity-encoded images. 
 Various materials were also tested in the development of this vascular phantom.    
A number of materials have been used in the past as MR quality control phantoms 
including rigid materials, such as glass [20], acrylic [21], and polyester [22], and those 
that are flexible, including silicone [23] and latex rubber [24].  These materials all exhibit 
MRI compliancy, but do not provide the most accurate results: glass, acrylic, and 
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polyester do not provide an MRI signal, while silicone and latex rubber do not have 
anthropomorphic properties [25].  Polyvinyl alcohol (PVA), which is a polymer that 
retains more than 20% water within its structure (hydrogel), has been shown to have 
excellent MR properties [25-28] and is consequently examined in this experimental 
validation study. 
The possibility of using MRI to accurately detect flow characteristics in the renal 
arteries may assist in reducing the number of invasive procedures required in diagnosis 
and disease progression evaluation.  Patients and their families are also far more likely to 
participate in research monitoring disease progression if this involves non-invasive 
studies, as opposed to those that are invasive, thereby providing a more detailed and 
accurate understanding of the pathology of the disease.  The study described in this report 
seeks to validate in vivo MR results, which will assist in treating a significant number of 
individuals afflicted with ADPKD.  As an established and accepted technology, velocity-
encoded MRI may ultimately be used to guide therapy in not only ADPKD, but also in a 










The Normal Kidney 
  
The kidneys (Figure 2-1 and 2-2) are part of a regulating system that perform a 
variety of functions.  They ensure that electrolytes, such as sodium, potassium, calcium, 
phosphorous, and other chemicals are in balance.  Kidneys produce several essential 
hormones and change vitamin D into its active form.  The kidneys also help regulate the 
pH of body fluids and filter and excrete waste products.  Kidneys filter blood plasma and 
produce urine, by which waste products are eliminated from the body.  When kidney 
function is impaired, these waste products cannot be eliminated from the body.  This 
causes a toxic condition known as uremic poisoning [29]. 
 Each person is normally born with two kidneys, which are located in the back of 
the body, on each side of the spine and positioned under the rib cage.  It is important to 
note that the left kidney is usually slightly larger than the right [30-31], which results in 
increased volume and dynamic flow values.  These organs are truly remarkable, as a 
single kidney can function at 20% of its capacity while still providing all required renal 
filtration and regulation [32].  Kidneys are normally about five- an-a-half inches long, 






Figure 2-1:  Anterior view of kidneys in situ. It is interesting to note that the left kidney 





Figure 2-2:  Kidney anatomy and enhanced view of nephron. [34] 
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a kidney may be approximated as the size of a human fist.  A kidney is comprised of 
approximately one million tiny tubes referred to as nephrons (Figure 2-2).  Up to twenty-
five percent of the blood that the heart pumps every second travels into the kidneys from 
the renal arteries and flows through the glomeruli, which are filters located in each 
nephron.  The glomeruli remove substances including urea, creatinine, and ureic acid.  
The kidney removes creatinine in such an efficient manner that the level of creatinine in 
the blood may be used as a diagnostic tool to determine kidney function.  This test is 
performed using results from a blood test and a twenty-four hour urine collection, along 
with height and weight, and is referred to as creatinine clearance or glomerular filtration 
rate (GFR) [1, 29]. 
 
 
Polycystic Kidney Disease Pathology 
 
Polycystic kidney disease (PKD) is diagnosed as two hereditary forms, and is 
characterized by renal cyst enlargement, interstitial fibrosis, and progressive deterioration 
of renal function in conjunction with the loss of normal renal tissue [1, 35].  Autosomal 
dominant polycystic kidney disease (ADPKD) is the most common of all life-threatening 
genetic diseases, and about 1 in 1000 people carry a mutant gene for the condition [36].  
In the past, it has sometimes been referred to as adult polycystic kidney disease, or 
APKD [37-39].    Autosomal recessive (ARPKD) often causes mortality in the first 
month of life; however, it is also very rare.  In the presence of PKD, cysts develop in the 
kidneys (Figure 2-3).  The appearance of cysts is variable and detection ranges from birth 
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to healthy individuals over eighty years of age [39]. The cysts may also spread to other 
organs, most commonly the liver.  Cysts may be as small as pinhead and may grow to be 
as large as a grapefruit.  The kidneys may grow to be larger than a football (Figure 2-4) 
and have weighed as much as thirty-eight pounds each in the presence of many cysts.  
ADPKD is usually caused by a mutant gene at the PKD1 locus on the short arm of 
chromosome 16; however, unknown mutations elsewhere in the genome cause the 
disease in approximately four percent of cases [4].  In these specific cases, if renal cysts 
develop, renal failure will most likely not occur until later in life.  Renal dysfunction due 
to the disease most often occurs in middle-aged individuals; however, a considerable 
number of diseased individuals remain asymptomatic [36, 40-41].   It has been estimated 
that approximately 53 percent of individuals will develop end-stage renal disease by the 
age of fifty-eight; however, this approximation does present a considerable amount of 
uncertainty (95 percent confidence interval, 0.34 to 0.72), as few patients over 50 years 
have been studied [40].   
Cysts begin as a blister-like occurrence of the nephron.  Most cysts detach when 
they are small and enlarge over time, becoming filled with fluid.  Three components to 
cyst formation have been determined.  The first is cell proliferation, in which the cells of 
a cyst wall reproduce more rapidly than normal kidney cells.  Therefore, the cysts 
become larger.  Cellular secretion is also a factor in cyst formation.  The cells produce 
fluid, which fills the cyst.  An abnormal basement membrane has also been found to 
contribute to cyst formation.  The basement layer is the thin layer of tissue that cyst cells 
sit on and is thicker than normal and has an unusual makeup in ADPKD patients.  Cysts 









Figure 2-4:  Comparison of polycystic kidney (left) with a healthy kidney (right). 
 [29] 
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number and size of the cysts [29].      
The most common clinical finding associated with the disease is flank pain [38].  
Hypertension is also a common symptom of ADPKD and has been shown to have an 
adverse and significant effect on kidney survival [37].  Hypertension is defined as 
persistent systolic or diastolic blood pressures greater than 150 or 100 mm Hg, 
respectively.  Numerous studies have confirmed the presence of hypertension in ADPKD, 
and some have suggested that this is the most common feature in symptomatic ADPKD 
[39].  Delaney et al. suggested that hypertension is easily treated; however, it does cause 
minor end-organ damage [38].  Hypertension is also significantly more prevalent in 
patients with renal cysts than those without [4]. 
 Intracranial aneurysms have also been classically associated with the disease. 
[37].  Other symptoms that have also been identified in patients suffering from ADPKD 
include symptomatic urinary tract infections, gross hematuria, and palpable masses [38].  
A number of disorders has been shown to be associated with the disease include gout [43-
44] arteriosclerotic cardiovascular disease [45], and colonic diverticulosis [46], and are 
noteworthy as each condition is a significant cause of morbidity and mortality [37]. 
 Clinical diagnosis has historically been based upon the presence of multiple 
bilateral cysts [37, 39].  These cysts have been discovered using a wide range of methods, 
including radiographic findings (excretory urography, angiography, and computed 
tomography), ultrasound, laparotomy, or surgical exploration.  In some instances, 
polycystic kidney disease may not be diagnosed until an autopsy is performed [37-38].   
By using ultrasonographic imaging, the disease may be diagnosed before symptoms 
develop.  If negative ultrasonographic images showing no bilateral cysts continue to 
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result during early adulthood, there is considerable assurance that a person is not affected 
[4].  Levels of creatinine in the blood are used to assess disease progression through its 
evaluation of kidney function; for example, renal functional impairment may be defined 
arbitrarily as a serum creatinine in excess of 2.5 mg/dL, while end-stage renal disease is 
defined as a serum creatinine greater than 8.0 mg/dL [38].  However, these values may 
vary; for example, chronic renal failure has been defined as a serum creatinine in excess 
of 1.5 mg/dL, while end-stage renal disease may be more broadly diagnosed as any 
individual requiring dialysis or transplantation [39].  In many patients, serum creatinine 
levels may remain elevated for a number of years before end-stage renal disease develops 
[47].   
 
 
Historical Perspective on Polycystic Kidney Disease 
 
In the 1700s and 1800s, PKD was often diagnosed as Bright’s disease.  This 
“disease” actually encompassed any one of several kidney diseases that were marked by 
high concentrations of protein in the urine.  The first documented case of PKD was 
Stefan Bathory, King of Poland, who lived from 1533 to 1588 [29].  Lejars provided the 
initial description of the disease in 1888 [48], and in 1957, Dalgaard established that 
ADPKD is transmitted as an autosomal dominant trait [36].  Although polycystic kidney 
disease has been the subject of numerous reports since it was first described, major 
advances were not made until fairly recently [2, 29].  It is also important to note that prior 
to 1970, cyst punctures were performed and retrograde pyelography was advocated, 
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which have been shown to distort the natural history of the disease [49-50].  Therefore, 
the results of series performed prior to the 1970s may not be valid [38]. 
As medical care and diagnostic techniques have continued to improve, ADPKD 
has been diagnosed earlier and more frequently since the late 1950s.  This has resulted in 
improved kidney and patient survival for affected individuals.  In a study following forty 
individuals identified between 1935 and 1980, Iglesias et al. presented that patients 
diagnosed between 1956 and 1980 had an improved survival rate compared to those 
diagnosed between 1935 and 1955 [37].  Although an antihypertensive therapy with 
resperine in the 1950s may have also contributed to the improved survival rate [37], the 
study suggests that the early diagnosis of adult polycystic kidney disease with modern 
techniques, combined with adequate medical attention, could possibly improve kidney 
and patient survival.  This study marked the first time the incidence rate of adult 
polycystic kidney disease was projected.  In this study, it was also shown that the 
presence of hypertension at the time of diagnosis had a significant influence on kidney 
survival, although it was not statistically shown that this led to an influence on the actual 
survival of the patient.  The presence of impaired renal function also was shown to 
influence kidney survival, but not patient survival.  
In 1985, Delaney et al. presented their results of a group of fifty-three 
symptomatic adults with APKD studied retrospectively for a mean follow-up of twelve 
years [38].  In this study, it was suggested that the deterioration of renal function is linear 
and renal calculi are frequent.  It was also demonstrated that urinary tract instrumentation 
induces serious infection that may cause death, and should be avoided.  In contrast with 
earlier series [51-52], Delaney et al. showed that pregnancy in women with APKD is not 
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contraindicated when renal function is normal [38].  In conclusion, this study suggested 
an improved prognosis for survival in the disease than previously reported. 
Today, ultrasound is used to diagnose ADPKD before the onset of symptoms in 
order to determine if renal cysts are present.  The presence of renal cysts establishes the 
diagnosis of the disease at any age.  Genetic studies are also conducted in many research 
facilities; in addition, ultrasounds are continuously conducted on children who may carry 
the PKD1 gene.  These ultrasonographic images are used in conjunction with genotypes 
inferred from linkage studies in order to diagnose the disease in individuals less than 
thirty years of age whose kidneys do not exhibit bilateral cysts [4].  However, some 
individuals may have family data that is insufficient for diagnosis, and in this case, 
imaging is the only method that may be used.  Although a number of imaging modalities 
exist, the majority of these techniques only provide anatomical information. 
Currently, no cure exists for ADPKD.  As the disease progresses, the kidneys fail, 
and dialysis or transplantation is required for patient survival.  Through diagnosis at an 
early age, and by monitoring disease progression, the side effects of this disease may be 
decreased and the quality of the patient’s life may be improved.  Recent research efforts 
focusing on the mutant genes that cause ADPKD have provided an interesting prognosis 
for the future, as it has even been proposed that gene replacement therapy may be 
possible based on recent information suggesting that ADPKD is recessive at a cellular 





Magnetic Resonance Imaging and Flow Quantification 
 
 Magnetic resonance imaging (MRI) is an established clinical imaging technique, 
and is constantly being used in new applications, many of which are quantitatively 
measuring flow velocities throughout the cardiovascular system.  MRI is becoming more 
prevalent for the purpose of obtaining both velocity and anatomic data for larger arteries 
in the cardiac area, specifically in major arteries directly connected to the heart, as well as 
the femoral artery [18, 54-56].  Despite the positive results obtained from these studies, 
the application of this noninvasive imaging modality to the renal arteries has been applied 
less often in clinical evaluation.  Early studies resulted in contrasting conclusions ranging 
from total lack of agreement to a good correlation between RBF measurements obtained 
using MRI and other, more established clearance methods used in the early 1990’s [57-
59].  However, current studies are consistently yielding more positive results [19, 60-62], 
suggesting that this technique may be used to accurately quantify flow in the renal 
arteries, in addition to the larger arteries comprising the cardiovascular system. 
 
 
Phase-Contrast Velocity-Encoded Magnetic Resonance Imaging 
 
Two specific sequences are used in clinical MRI, resulting in two types of images: 
spin echo and gradient echo.  These sequences are used to obtain complementary 
information pertaining to the anatomy (spin echo) and the motion of blood (gradient 
echo) in the specific area under observation.  Spin echo results in flowing blood 
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appearing black and is generated by applying an RF pulse that tips hydrogen protons by 
90° followed by a second 180° pulse.  These types of sequences are used to provide static 
anatomic information allowing for the differentiation of tissues.  Despite only one image 
being acquired per location, spin echo images have a number of advantages, which will 
be further discussed in Chapter IV.  Gradient echo sequences are produced by applying 
RF pulses less than 90° and result in images where flowing blood appears white.  These 
sequences are often substantially shorter than those defined as spin echo, allowing breath-
hold scans to be performed.  Gradient echo sequences provide less anatomical 
information as compared to spin echo sequences, and are accordingly used to obtain 
velocity information.  As technology has improved, magnetic resonance imaging using a 
gradient-echo technique with velocity encoding has become a prevalent source used to 
obtain flow measurements through the aorta and other large vessels in the cardiac system.  
For the purposes of the present validation study, a gradient echo sequence was used to 
obtain the flow data using the PVA phantom. 
Phase-contrast magnetic resonance imaging (PC MRI), an example of a gradient 
echo sequence, is an emerging technique for measuring regional blood flow [18-19, 54-
62].  A brief summary of the technique is presented here, with a more detailed 
explanation provided in Chapter IV: Instrumentation and Experimental Methods.  This 
technique is based on the principle that the signal from flowing hydrogen nuclei, relative 
to those that are stationary, accumulates a phase shift that is proportional to the velocity 
of flow when passed through specifically-designed magnetic field gradients.  When using 
this type of imaging sequence, two images are acquired: the magnitude image, which 
provides anatomical information, and the phase image, which is velocity-encoded and 
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provides velocity information.  Numerous phase images are constructed across the 
cardiac cycle in which the brightness of the voxel is proportional to the blood velocity 
within that voxel.  Regions of interest around a vessel are then defined using specialized 
software, and the flow rate is automatically calculated based on the specific contour 
defined.   
Numerous studies have been performed showing that phase-contrast velocity-
encoded MRI is a technique that provides accurate regional hemodynamic information, 
both in vivo and in vitro, which address larger arteries found in both children and adults 
[10, 18, 54-55, 63-69].  Clinically, this technique has been used to quantify cardiac 
output, the pulmonary-to-systemic flow ratio, valvular regurgitation, differential lung 
perfusion, and coronary flow [56].  It has also been shown that shear stresses may be 
calculated using this sequence when flow encoding is performed in three orthogonal 
directions [70].   
 
The Application of PC MRI to the Renal Arteries 
The use of PC MRI has been proven to be of clinical value in the evaluation of 
flow in the larger arteries of the cardiovascular system.  Blood flow may be measured in 
vessel cross-sections at various points in the cardiac cycle at high temporal and spatial 
resolution [54].  However, less experimentation has been performed using this 
noninvasive technique in renal applications, where smaller arteries are present.  In order 
to quantify flow through the renal arteries previously, Doppler signals were recorded and 
81Rb/81mKr ratios were compared to evaluate renal function [71-72].  Since the early 
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1990’s, both in vivo and in vitro studies have been performed in order to observe how 
velocity-encoded MRI may be applied to image the renovascular system.  
Sommer et al. showed in 1992 that PC MRI could be used to obtain reproducible 
noninvasive measurements of RBF [57].  Although a high degree of reproducibility was 
observed in this study, the MRI measurements of arterial flow did not agree significantly 
with the standard measurements using the para-amino-hippurate (PAH) clearance 
technique in nine normal volunteers.  However, Sommer et al. did observe a correlation 
of 0.86 between the RBF estimated using MRI and the RBF calculated using the PAH-
clearance method from the left renal vein. 
More promising results were presented in 1993 by Lundin et al. [59].  Using two 
different RBF measurements found using MR angiography (sum of flows in right and left 
renal arteries and difference between supra- and infrarenal abdominal aorta flow), they 
found the correlation coefficient between the two flow rate calculations to equal 0.72.  A 
comparison of the MR results and expected RBF measurements found using the PAH 
clearance was made, and agreement was observed among the values.  Based upon their 
results, Lundin et al. also suggested that noninvasive RBF measurements were possible 
using PC MRI methods. 
In the same year, Wolf et al. further suggested that cine PC MRI was a promising 
technique for measuring blood flow when applied to the renal arteries [58].  Using a total 
of ten healthy adult volunteers, flow data using velocity-encoded MR images was again 
calculated by measuring the difference between suprarenal and infrarenal aortic flow.  
Individual arteries were also imaged in order to obtain through-plane flow.  These results 
were then compared to RBF measurements found using the PAH-clearance method.  
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Wolf et al. pointed out in their discussion that the PAH-clearance method has a number 
of limitations.  When using this method, only healthy subjects with normal renal function 
may be monitored, temporal resolution is poor, and most importantly for the purposes of 
a number of renal diseases, the kidneys cannot be studied separately.  The PAH-clearance 
method would not allow observation of patients with impaired renal function.  
Measurements of the individual renal arteries resulted in more correct results than the 
flow data calculated using the aortic subtraction method, as compared to the PAH-
clearance values.  Wolf et al. also emphasized the importance of minimizing the velocity 
encoding value and reported that more accurate results were obtained as the velocity 
encoding value was decreased.   
In 1994, Debatin et al. [73] used a cine PC MRI sequence, in addition to two 
breath-hold PC techniques, to determine the most correct method of obtaining reliable 
RBF measurements.  After performing in vivo and in vitro experiments, they were able to 
show that it was possible to acquire consistent RBF measurements using breath-hold PC 
MRI.  For the in vivo study, the PAH clearance technique was again used as the 
established method for comparison to the MRI data in eight patients.  Based upon their 
results, Debatin et al. commented that breath-hold sequences were significantly more 
accurate than conventional cine PC sequences both in vivo and in vitro.  Overestimation 
of flow resulted from the use of the cine PC technique. 
In the three studies presented above, flow rates obtained using MR were 
compared indirectly with measurements obtained using MR imaging of the aorta [59] 
and/or through clearance techniques [57, 59, 73].  In 1997, Schoenberg et al. surgically 
implanted transit-time ultrasound flow probes in seven foxhounds to compare MR 
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measurements more directly to a specially-designed cine PC MR protocol [60].  When 
the cine PC MR results were statistically compared to the flow probe data, a correlation 
coefficient of 0.99 resulted.  Through the results of this study, Schoenberg et al. were 
able to show that cine PC MR could be used to provide a reliable quantification of RBF.  
They also commented that this technique proved to be sensitive to hemodynamic changes 
and provided an accurate assessment of the pulsatile flow signal.  With such a strong 
correlation between the two techniques, Schoenberg et al. suggested that their cine PC 
MR protocol had the potential to be a reliable method for obtaining a quantitative and 
qualitative assessment of RBF, thereby one day replacing the invasive measurement 
techniques widely used at that time. 
In 2000, de Haan et al. presented their results focusing on the differences 
observed when using breath-hold and respiratory-triggered PC MRI [61].  Using twelve 
healthy subjects, they found that both techniques were valid and reproducible, although 
results obtained using the breath-hold method were slightly more accurate.  De Haan et 
al. also used the difference in aortic flow measurements above and below the renal 
arteries as their validity control.  It was emphasized in this report that further and larger 
studies, which included the observation of diseased patients, were required prior to the 
extensive application of this technique to quantitative imaging of the renal arteries. 
De Haan et al. published their results from a follow-up study using the 133Xenon-
washout procedure as an independent comparison method in 2003 [62].  This report 
described the results of a much larger study, which included fifty-three patients suspected 
of having renovascular disease.  Up until this time, no large-scale studies on diseased 
patients had been performed.  De Haan et al. again showed that a significant correlation 
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existed between PC MR and an independent control method (133Xenon-washout 
procedure).  In contrast, they pointed out that the MR data did not compare well with the 
severity, or presence, of renovascular disease using angiography.  Based upon their 
results, de Haan et al. stressed that the PC MR technique required further experimentation 
and improvement before its clinical application on a larger-scale. 
Finally, in 2003, King et al. presented a comprehensive study using one hundred 
twenty-seven patients diagnosed with ADPKD [19].  A large amount of information was 
acquired during this study, including both anatomic and hemodynamic data.  The in vivo 
flow data acquired using a 2D cine phase-contrast breath hold sequence was found to be 
both valid and reproducible.  King et al. also demonstrated that compromised flow in the 
renal arteries correlated with other anatomical and functional characteristics of ADPKD 
severity.  As a result, they suggested that MR has great potential for investigating 
hemodynamic changes that occur with disease progression, and may be more widely 
applied in the future with additional experimentation.   
The studies discussed in this chapter have all presented important information that 
have contributed to the advancement of noninvasive imaging techniques, specifically as 
applied to the renal arteries.  It is important to note that many of these studies were 
limited by small sample sizes.  Although nearly all reports presented promising results, 
the accepted standard used to image the renal arteries is still contrast angiography [74], 
which may be performed using a variety of modalities including sonography, computer 
tomography, and MR.  Currently, the preferred MR angiography (MRA) technique is 
high-resolution 3D gadolinium-enhanced MRA [61, 75].  In addition to the requirement 
of contrast agents, these modalities have certain limitations, as they rely on morphologic 
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assessments of the arteries [73].  PC MRI allows a noninvasive quantitative evaluation of 
flow dynamics to be performed, which cannot be achieved using angiographic 
techniques. 
Because there is a growing population of individuals being diagnosed with 
ADPKD, as well as other renovascular diseases, the ability of diagnostic imaging 
modalities to provide both anatomical and functional information pertaining to the renal 
arteries is of particular importance.  MRI is ideally suited to become the primary imaging 
modality for the patient population affected by this disease, as it can provide a large 
amount of information (velocity data, flow quantification, cyst volume, and kidney 
volume) obtained during a single scan session.  MRI is also noninvasive and biologically 
harmless, which may further increase patient cooperation in clinical studies.  Because of 
its numerous applications in comparison to its few limitations, MRI has the potential to 
be the imaging modality of choice in the future for the purposes of quantifying flow, as 
well as for other anatomical and functional purposes, throughout the many areas of the 
cardiovascular system.  Although numerous studies have been performed using PC MRI 
to image the cardiovascular system, the focus has been on larger arteries.  In addition, the 
majority of the studies on renal arteries concentrate on using PC MRI to obtain data from 
healthy adults.  A substantial amount of RBF data does not exist for diseased individuals 
or children.  Thus, the present validation study aims to formulate a protocol that may be 






HYPOTHESIS AND SPECIFIC AIMS 
 
  
The long-term goals of the CRISP study include the ability to more completely 
understand how MRI may be used to assess renal circulation and the role that 
hemodynamic changes have in renal disease progression, specifically in ADPKD.  King 
et al. have shown that a significant correlation exists between the anatomical and 
functional indicators of ADPKD disease severity and the hemodynamic parameters 
measured in the renal arteries [19]; however, the mechanism behind this correlation must 
be further understood in order to develop an effective preventative treatment program.  In 
order to ensure that these in vivo measurements are as accurate as possible, a number of 
experiments must be performed in vitro.  These experiments will result in the 
determination of an effective protocol for assessing the wide range of individuals this 
disease affects.  By combining the knowledge gained from both in vitro and in vivo 
studies, methods to monitor disease progression and the development of a treatment plan 
to reduce the effects of rapidly changing hemodynamic parameters may be developed.  
The present study uses current MR techniques to test the following hypotheses and 




 The first hypothesis of this study is that polyvinyl alcohol (PVA) is a superior 
phantom material for modeling vascular tissue in MR flow simulations. 
 The specific aims resulting from this hypothesis are: 
 
Specific Aim 1: 
To investigate MR velocity results from: 
(a) PVA cryogel, 
(b) Plastic tubing (vinyl, containing polyvinyl chloride compounds), and 
(c) Glass models 
in order to establish the most accurate material for modeling human vessels. 
 
 This aim will be achieved through in vitro experiments.  A phantom will be 
designed using a block of PVA constructed with six hollow channels.  MR measurements 
will be taken through the center of this cryogel block, as well as through plastic tubing 
exiting the phantom to capture flow characteristics through both materials.  These results 
will be compared to results previously obtained in this and other studies to determine the 






 The second hypothesis of this study is that breath-hold velocity-encoded MRI is 
capable of producing highly accurate flow measurements for the physiological range and 
dimensions of renal arterial blood flow.   
 The specific aims resulting from this hypothesis are: 
 
Specific Aim 2: 
To investigate the ability of MR to accurately determine velocity and flow in renal 
arteries. 
 
 This aim will be achieved through in vitro MR studies using a PVA cryogel 
phantom.  The resulting measurements will be compared to actual flow calculated using 
collected volume by weight determination. 
 
Specific Aim 3: 
To formulate an effective protocol resulting in precise flow measurements, which may be 
applied to in vivo studies and further used to quantify hemodynamic changes in patients 
with renal insufficiency. 
  
 This aim will be achieved using a breath-held phase-velocity encoded protocol 
with the PVA cryogel phantom.  A number of parameters will be tested in order to 
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determine exactly which protocol provides the best results and should subsequently be 





INSTRUMENTATION AND EXPERIMENTAL METHODS 
 
 
 In this chapter, the experimental model, the in vitro flow loop, and the 
experimental techniques and protocol are discussed.  The process for analyzing the data 
collected during the various magnetic resonance (MR) experiments using a breath-held 
gradient-echo technique is also explained in detail. 
 
 
In Vitro Model 
 
The experimental model (Figure 4-1) used in this validation study was a square 
box made of cast acrylic sheets (constructed by J.M. Machining, Lawrenceville, 
Georgia).  The box measured 24.13 x 24.13 x 6.99 cm, and was made of 9.52 mm cast 
acrylic with a 6.35 mm cast acrylic lid held in place with plastic flat head screws.  
Adhesive was used to glue the cast acrylic sheets together forming the square casing.  Six 
holes of decreasing diameter were machined onto opposite sides of the box into which six 
Teflon tubes with six different diameters were inserted.  The diameters of the holes were 










Figure 4-1: PVA phantom used in validation experiments.  The model was constructed 
with six hollow channels running through the PVA ranging in diameter from 
3.18 to 11.11 (± 0.01) mm.  PVA proved to be the superior choice among 







chosen to simulate the full range of vessel diameters encountered in renal arteries in both 
a healthy and diseased population of children and adults [73]. 
In the process of validating renal blood flow measurements from magnetic 
resonance imaging (MRI), various model materials were evaluated.  Initial 
experimentation was performed using polyvinyl alcohol (PVA), vinyl tubing, made of 
polyvinyl chloride (PVC) compounds, and glass.  These results are presented in Chapter 
V, and as shown, results from the vinyl tubing and plastic did not prove to be as accurate 
as PVA in terms of resulting MRI data.  After these initial results were evaluated, PVA 
was selected as the material of choice because of its mechanical and magnetic properties 
for simulating vessel lumen in in vivo blood flow measurements [25].  The chemical 
structure of PVA is shown in Figure 4-2 for reference purposes.   
PVA was first recognized to have medical applications by Nambu in 1982 [76].  
Since that time, it has been reported to be ideal for a number of different medical 
purposes.  PVA has been used as a skin marker in MR [77-78] and x-ray imaging [77, 
79], a transmission pad in radiofrequency thermal therapy [80], a conductive 
electroretinographic membrane [81-83], a bandage for burn victims [84-85], a substitute 
for an ice bag [86-87], and other medical applications [88-89]. Most importantly, for the 
purposes of this study, PVA has been shown to be ideal as an MR quality control 
phantom material [25-28], as PVA yields enough free protons to yield above-noise 
signals with most MRI pulse sequences, unlike glass, plastic and rubber.  The strength 
and elastic characteristics of this material are also mechanically comparable to the vessel 
wall [25].  In 1997, Chu and Rutt described how PVA is inherently flexible and tough, 












Figure 4-2: The chemical structure of the polyvinyl alcohol molecule.  PVA has been 
reported to have a number of significant medical applications including its 




These relaxation properties are stable over a six-month period of time [26], and although 
some researchers feel that more than six months is required for an MR quality control 
phantom to be of clinical use and significance [90-91], it is important to note that this 
material may be easily reproduced in a fairly short amount of time. 
The specific PVA cryogel used in this study was created by freezing and thawing 
an aqueous PVA solution.  During these freeze-thaw cycles, cross-linking occurs through 
hydrogen bonding with hydroxyl groups between the PVA molecules.  This cross-linking 
determines the strength characteristics of the rubber-like gel material.  Strength 
characteristics may be altered using chemical cross-linking, initiated through the addition 
of compounds such as aldehydes or borates [92]; however, for the purposes of this study, 
an aqueous PVA solution proved to be the best choice.  In chemically altered PVA 
cryogels, the result is that of a gel having the appearance and strength similar to common 








Evaluation of Materials 
 
 In order to determine which material would provide the most accurate results 
for this validation study, three materials were evaluated: clear vinyl tubing composed of 
polyvinyl chloride (PVC) compounds, glass, and polyvinyl alcohol (PVA).  In order to 
assess the accuracy of these materials, experimental flow rates resulting from the phase-
velocity image analysis described above was compared to the experimental flow rates at a 
200 mm field of view (FOV).  Results for the clear vinyl tubing and the PVA were 
compared to the flow rates presented in Table 4-1 for channel diameters of 3.18, 4.76, 
and 11.11 mm, as the vinyl tubing was most perpendicular to the scan plane in these 
instances.  Data for these materials was taken simultaneously using the procedure 
described later in this chapter.  Using the same analysis methods described with the 
FLOW software package, a glass model from a previous study [93] was used as a third 
material for comparison.  The vinyl tubing continued to be imaged throughout the 
validation study after initial experimentation in order to further demonstrate the 




 Once it was shown that PVA is a superior phantom material for the purpose of 
MRI research, the most effective procedure and ratio of PVA to water in the cryogel 
solution had to be determined.  In order to address this issue, two phantoms were made 
using different amounts of PVA in each (20% and 30%).  Three different sizes of beakers 
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were also used to determine the best method of autoclaving the solution.  The flow loop 
described in the next subsection was set up in an experimental laboratory, and each 
phantom was placed inside the cast acrylic box and incorporated into the flow loop.  The 
performance of each phantom was observed during this “dry” experimental run, and the 
amount of leakage by the phantom was especially noted.  
In order to create a mold that would be of sufficient strength and elasticity to 
retain its shape under fluid pressures encountered in vivo, a solution of 30% hot-water 
soluble PVA and 70% water was used.  The polyvinyl alcohol slab was formed using 
2500 ml of the aqueous PVA solution.  After the solution was mixed, it was autoclaved 
on the liquid cycle for thirty-five minutes to allow it to go into solution, as the PVA used 
in the phantom construction is only soluble at higher temperatures.  After testing with 
various sizes of autoclavable containers, it was found that using 1000 ml beakers with 
500 ml of solution in each was the most appropriate method, preventing spillover during 
the autoclaving process.  The resulting solution was then poured into the cast acrylic 
casing, where six Teflon tubes of corresponding diameter had been inserted into their 
appropriate straight holes.  Care was taken in pouring the solution into the casing as to 
not allow any air bubbles to form in the area to be scanned.  Air bubbles were also 
removed before beginning the freeze-thaw cycles.  Once the solution had been poured 
into the casing, the lid of the case was attached with metal screws.  The entire phantom 
was then placed into a freezer to begin freeze-and-thaw cycles.  These cycles occurred at 
twelve-hour intervals, and were placed in water at room temperature during the thaw 
cycle to ensure that the PVA would not lose its mechanical properties.  According to Chu 
and Rutt, the length of time frozen does not have a large influence on the properties of the 
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PVA [25].  The time intervals were chosen to ensure that access to the freezer would be 
available.  Four freeze-and-thaw cycles were used, as research suggests that additional 
cycles would make no substantial difference in the PVA properties.   It was also noted 
that a minimum of four cycles was required to allow cross-linking to occur throughout 
the entire model.  Once the freeze and thaw cycles were completed, the PVA phantom 
was stored in water at room temperature to maintain its properties.  The metal screws 
used during freeze and thaw cycles were also replaced with those made of plastic before 
the phantom was placed in the scanner, ensuring MRI compatibility and reducing the 
incidence of artifact. 
 
 
Steady Flow Loop 
 
 A steady flow loop was created in order to allow flow quantification to be made 
using MRI.  A schematic showing the setup for the 9.53 mm experiment is shown in 
Figure 4-3.  The fluid used in the experiments matched the kinematic viscosity of blood 
(3.5±0.1cSt) and was a solution of 40% glycerin and 60% water by volume.  Teflon 
tubing was inserted into the casing described in the previous subsection to serve as entry 
length tubing, ensuring fully-developed flow within the model.  These tubes were 
inserted through the holes in the casing, approximately one inch into the PVA mold.  The 
proper entry lengths were calculated according to Equation (4-1), 
 




























Figure 4-3: Flow loop used in steady flow validation experiment.  This schematic shows the setup for the 9.53 mm experiment.  It is 
also important to note that PVC tubing was returned over the phantom model in order to capture flow through the vinyl 


















where Re is the Reynolds number and D is the inner diameter of the tube.   The Reynolds 





=Re  (4-2) 
 
where V is the velocity, D is the diameter, and ν is the kinematic viscosity of the fluid in 
centiStokes.  In these calculations, a kinematic viscosity of 3.4 centiStokes was used.  
Based upon the entry length calculations, the range of entry lengths varied from 3.74 to 
22.47 cm using the kinematic viscosity stated above.  Therefore, all entry lengths were 
cut to be 25 cm to ensure fully-developed flow at all possible rates of flow and to account 
for slight variations in fluid viscosity.  Temperature was also monitored to maintain 
accurate viscosities throughout the duration of each experimental trial using a standard 
thermometer (Enviro-Safe -20 to 110°C, H-B Instrument Company, Collegeville, PA).  
The temperature of the fluid was maintained at 21°C by keeping the pump iced 
accordingly.  
In order to make the appropriate connections to the six different inlets, three 
different sets of flexible vinyl tubing subsections were made, which could be integrated 
into the main flow loop.  Each subsection was created so that it would fit onto the inlet 
and outlet Teflon tubing of two consecutive diameters.  Fluid was run through one 
channel at a time with only that channel integrated into the main flow loop.   
For every diameter existing in the model, six flow rates were tested, resulting in 
thirty-six sets of scans ranging experimentally from 120 to 1190 ml/min.  Beginning with 
the smallest diameter of 3.18 mm, flow rates were tested from 120 to 760 ml/min at 
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increments of approximately 100 ml/min.  Flow rates were measured with a rotameter 
(model 6B0202, Dakota Instruments, Monsey, NY and model H404020030, Bel-Art 
Products, Pequannock, NJ) that was placed directly after the adjustable control valve in 
the experimental flow loop.  The return outlet of the phantom model drained into the 
same initial reservoir, from which the fluid was pumped via a submersible pump (model 
number 550, Little Giant, New Haven, CT).  True flow rates were calculated by weighing 
the fluid from the return loop over a one-minute interval.  With the exception of the 
highest two flow rates in the 11.11 mm experimental trial, fluid was collected both before 





During each scan session, one simulated vessel was used for experimentation.  The 
collected fluid obtained from the return loop was transported away from the scanner and 
taken to a separate experimental laboratory within Emory University Hospital in order to 
prevent any spills in the scanner room.  As previously discussed, fluid was collected 
twice at each flow rate for each simulated vessel.  One sample measuring 500 ml of fluid 
from the reservoir was then measured and weighed using a standard balance (model 
TM3000, Mettler Toledo, Columbus, OH).  Once the resulting weight of the sample had 
been recorded, each individual fluid sample for each rate of flow was weighed and the 
volume was calculated, resulting in two experimental flow rate values (ml/min) for each 
flow rate.  These values were then averaged and the resulting volume was used as the true 
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flow rate, which served as the baseline in the MRI validation.  The two measurements 
taken for each flow rate were all within 3% of one another, the majority of flow rates 
being within 1%.  The resultant flow rates are shown in Table 4-1.  Please note that two 
fluid samples were not collected during experimentation with the two highest flow rates 
for the largest diameter (11.11 mm).  This was due to higher flow rates used and size 
limitations of the fluid collection apparatus.  For these two flow rates, sampling occurred 







Table 4-1:  Experimental flow rates measured using the weight determination method.  
The listed flow rates are an averaged value of the fluid collected prior to the 
first scan and after the last scan, with the exception of the two highest flow 




3.18 4.76 6.35 7.94 9.52 11.11
123.35 278.09 336.95 477.22 532.07 694.37
242.13 411.72 457.93 573.09 706.87 796.64
377.96 510.04 654.48 691.37 795.88 851.56
397.69 660.25 686.06 787.15 808.22 919.18
531.19 771.37 743.88 896.50 964.40 1010.44







Principles of Magnetic Resonance Imaging 
 
Nuclear magnetic resonance (NMR) tomography, now recognized as MRI, is 
based upon the principle of NMR.  Although the word "nuclear" was dropped from the 
term “MRI” in the late 1970s, as to not associate MRI with ionizing radiation, the 
occurrence of this technique actually originates in the nuclei of atoms.   In clinical MRI 
today, magnetic fields and radiofrequency energy are most frequently used to stimulate 
hydrogen nuclei in selected regions of the body.  Hydrogen is one of many NMR active 
elements.  Other biologically important elements that share this characteristic include 
carbon, nitrogen, oxygen, fluorine, sodium, phosphorous, chlorine, and potassium [94].  
As these hydrogen nuclei are stimulated, they emit radio waves that are then used to 
construct images [69].  These MRI signals have frequency, amplitude, and phase 
components, just as other types of waves.   
The principle of NMR is established by two main properties: nuclear spin and 
also that moving charged particles give rise to a magnetic field (Figure 4-4).  Nuclear 
spin causes elementary particles, which are contained in nuclei, to have an intrinsic 
magnetic field associated with them. In the absence of an external magnetic field, these 
particles (protons) are in complete disarray; however, if they are placed in a strong 
magnet, they will have a tendency to align in the presence of an external magnetic field.  
For protons, only two alignments are possible using an applied magnetic field: either with 






                (a) B0 not applied                    (b) B0 applied  
 
 
Figure 4-4: This diagram displays the two main properties of NMR. (a) In the absence 
of an external magnetic field, a hydrogen proton has an intrinsic magnetic 
field due to the property of nuclear spin.  (b) When an external magnetic 
field (B0) is applied, the spinning proton not only spins about its own axis, 







  (a) B0 not applied               (b) B0 applied   
 
 
Figure 4-5: (a) A representation of the chaotic array of hydrogen protons when an 
external magnetic field (B0) is absent and (b) the alignment that occurs when 
the magnetic field is applied.  In (b), the bars above and below the protons 
represent the poles of the magnet.  In MRI, protons may either align with the 
direction of the magnetic field or against it, resulting in two different energy 
states.  In this example, when B0 is applied, the first two columns represent 
the lower energy state, as these protons align in the direction of the external 





between these two energy states is directly proportional to the strength of the external 
magnetic field and is governed by Equation (4-3), 
 
 0BE γ=∆  (4-3) 
 
where γ is the gyromagnetic ratio of the nucleus and B0 is the strength of the external 
magnetic field.  For a proton, γ equals 7107.1 −× eV/T (42.58 MHz/T).  When using an 
applied magnetic field of 1.5 T, the energy difference as described in Equation (4-3) is 
equivalent to 7106.2 −× eV.  This is approximately one ten-billionth of the energy used in 
X-ray and nuclear medicine. 
 In order to perform an MRI experiment, radiation must be sent into the protons in 
a specific sample at the frequency at which they will absorb the radiation.  This frequency 
is identical to the energy difference between the two possible alignment states, and in the 
case of the 1.5 T applied magnetic field, this frequency would be 63.87 MHz 
( 7106.2 −× eV).  The radiation is only applied for a short time and is referred to as a 
radiofrequency radiation (RF) pulse.  After the sample is excited, it emits an RF signal 
that must be received and quantified in order to produce the MRI image.  The 
transmission of the excitation pulse and the receiving of the resulting RF signal are 
performed by the RF coil, which acts as both a transmitter and receiver.  For each and 
every MRI study, a number of steps are taken.  A pulse sequence is selected, an image 
location is chosen, and image data is acquired in order to address specific questions 
relating to each individual case.  Each pulse sequence is defined in order to determine 
how the magnetic field gradients are applied during image acquisition.   
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 During the past fifteen years, clinical MRI has evolved from a modality that was 
restricted to anatomic imaging to one that also provides functional information.  Two 
specific sequences are used in clinical MRI, resulting in both types of images: spin echo 
and gradient echo.  Spin echo results in flowing blood appearing black and is generated 
by applying an RF pulse that tips hydrogen protons by 90° followed by a second 180° 
pulse.  These types of sequences are used to provide static anatomic information.  
Although only one image is acquired per location, spin echo images have a number of 
advantages.  These include high spatial resolution, blood-tissue contrast, and decreased 
artifact caused by metallic biomedical implants [56].  Gradient echo sequences are 
produced by applying RF pulses less than 90° and result in images where flowing blood 
appears white (+ vmax).  At v = 0, the image appears medium gray, and at a maximum 
“negative” velocity (- vmax), the image is black.  These sequences are often substantially 
shorter than those defined as spin echo, allowing breath-hold scans to be performed.  
Multiple images may also be acquired over the cardiac cycle in each predetermined 
location, allowing flow characteristics to be defined and arterial and ventricular function 
to be assessed. 
Phase-contrast magnetic resonance imaging (PC MRI), an example of a gradient 
echo sequence, is an emerging technique for measuring regional blood flow [17-18, 54, 
56, 60-61], and is used throughout this renal phantom validation study.  PC MRI is also 
referred to as phase-velocity cine MRI (PVC MRI) and velocity-encoded cine MRI [69].  
The ability to acquire quantitative measurements of blood flow non-invasively is a 
valuable tool that has resulted from improved technology.  In order to obtain the flow 
characteristics through a vessel, an image plane is oriented perpendicular to the direction 
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of flow through the vessel.  A cross-sectional image with velocity encoded in the 
through-plane direction results, and both the modulus, or magnitude, and phase images 
are acquired at various points during the cardiac cycle.  The modulus image provides 
information about the anatomy of the patient, while the phase image contains the velocity 
information.   
PC MRI is based upon the principle that the signal from hydrogen nuclei, such as 
those found in the blood, accumulates a predictable phase shift, which is proportional to 
flow velocity.  The fact that spin echoes resulting from magnetization moving along a 
magnetic field gradient experience phase shifts was recognized early with the use of MR 
[95].  In PC MRI, specially designed magnetic field gradients, whose strength varies 
linearly in the direction of blood flow, are briefly applied to the specific location being 
examined.  Protons at different locations along the gradient develop phase differences, as 
a result of the rate of proton precession (complex rotation of the spinning proton) being 
proportional to the strength of the magnetic field.  The gradient is then reversed, giving it 
opposite polarity.  No net phase shift is acquired by nuclei in stationary tissue because the 
gradient cancels out any phase change, and therefore, this tissue appears gray.  However, 
moving protons experience a different gradient strength when the second gradient is 
applied.  The application of this bipolar gradient results in a net phase shift (φ) being 
accumulated proportional to the velocity of the protons in the velocity-encoded direction.  
This is governed by Equation (4-4), 
 




where v is the velocity and ∫ tdttG )(  is the first moment of the gradient G(t) in the  
direction of flow [60, 69].  Moving fluid is displayed through the intensity of each voxel 
in the phase image and may appear bright or dark, depending on the direction of flow.  
Background phase shift phenomena may be attributed to a lack of homogeneity in the 
magnetic field and other factors, resulting in inaccurate images.  These effects may be 
accounted for by acquiring a second set of phase data without velocity encoding.  By 
subtracting the two sets of phase data from one another, the background error may be 
removed, resulting in more accurate results [69].   
Velocity encoding may also be performed in all three orthogonal planes (RL, AP, 
FH); however, these studies are performed with less temporal resolution.  This type of 
encoding results in three phase images at each point measured during the cardiac cycle 
and was used in this renal validation study in order to determine flow characteristics and 
establish any deviation from steady, laminar flow.     
 
 
Magnetic Resonance Imaging Techniques and Protocol 
 
Four main studies were performed using the PVA validation phantom and the 
steady flow loop described in this chapter, in addition to the MR studies performed using 
different materials.  All experiments were performed using a gradient-echo sequence, 
specifically using multi-shot echoplanar imaging (FE-EPI).  These studies include a 
comparison among high-resolution protocol at various fields of view, an assessment of 
the variations in low- and high-resolution scans, a multi-site study, and a study observing 
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the effects of velocity encoding in three directions.  All studies were performed on the 
Philips Gyroscan Intera 1.5 T scanner located at Emory University.  The 4-element, 
phased array body coil was used to transmit and receive RF signals.  Cardiac triggering of 
the MRI acquisition was performed using the Philips’ built-in physiology simulation 
software.  The high-resolution and low-resolution breath-held 2D PC MRI protocol, 
listed in Table 4-2, was used at each flow rate with a 160 x 160, 200 x 200, and 350 x 350 
mm field of view (FOV).  These will be referred to as the 160, 200, and 350 mm FOV 
from this point forward.  Visually defined perpendicular planes were also imaged in three 
locations along each channel using the high-resolution protocol at 200 mm FOV in order 
to study repeatability and to also ensure a uniform velocity profile along the length of 
each simulated vessel.  A study was also performed using a gradient echo protocol with 
velocity encoding in three directions at 240 x 240 mm FOV to assist in determining the 









Low-Resolution High-Resolution Velocity 
Encoding-
 3 Directions
TR (ms) 21 24 24
TE 11 11 11
Flip Angle (o) 35 35 35
Phase Encoding Views 96 192 192
Phases (across cardiac cycle) 16 16 12
Image Size 256 x 256 256 x 256 256 x 256
Field of View (mm x mm) 160 x 160, 200 x 200, 160 x 160, 200 x 200, 240 x 240
350 x 350 350 x 350  
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Magnetic Resonance Image Analysis 
 
Phase-velocity encoded protocol results in two images: the modulus and the phase 
difference images.  After each scan session was completed, all resulting image data was 
transferred to a Sun analysis workstation (Sun Blade 100, Sun Microsystems, 
Mountainview, CA).  The flow analysis was performed using the FLOW software 
package (University of Leiden, The Netherlands).  The definition of the lumen borders 
was performed manually first in the magnitude map and then the phase difference 
(velocity) map using the drawing tools provided with the FLOW software program.  The 
contours were drawn into the magnitude map based on visual perception of where the 
lumen boundary existed, while a velocity of 0 cm/sec was used to define the contours in 
the velocity map.  A third flux region was then defined using the software’s built-in 
contour detection program on the phase-velocity map.  This required the manual 
identification of a center point (using the “point” edit tool) inside the cross-section of 
each phase image acquired across the cardiac cycle.  A fourth region of interest (ROI) 
was drawn in a C-shape around the simulated vessel in order to correct for any static 
velocity components resulting from DC phase errors in the image background.  Data 
processing for the four regions of interest took approximately ten minutes for each scan.  
A typical image of the screen layout observed using the FLOW software package after 
manual and automatic contour definition is shown in Figure 4-6.  Flow rates were 
calculated with and without the inclusion of the fourth region in order to observe any 
constant velocity errors that were present across the image.  Instantaneous flow was first 
calculated from the information contained in the phase-velocity maps by integrating the 
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flow velocity values for each pixel within the first three regions of interest, with and 
without background subtraction.  Total flow per minute was then calculated by 
integrating these instantaneous flow values for each acquired phase across the complete 
cardiac cycle and multiplying by the heart rate in beats per minute as defined by the 
physiological simulation built into the Philips’ scanner.  Flow rates were calculated for 
each region of interest in each image to evaluate both the manual and automatic methods. 
Manual and automated image analyses were performed by two blinded 
independent observers for high-resolution scans at 160 and 200 mm FOV for all 
simulated vessels at a mid-range rate of flow (Table 4-3) to assess interobserver 
variability.  To assess intraobserver variability, the first observer repeated analysis on 160 
and 200 FOV to detect any significant changes in definition.  For both the interobserver 
and intraobserver studies, all simulated vessels were analyzed at the same flow rates to 








Figure 4-6: Sample screen layout using the FLOW software package.  The first region  
of interest (red) was drawn manually in the modulus image (right), while the 
second region of interest (green) was drawn in the phase image (left).  The 
third region of interest (white) was created using the automatic contour 
detection algorithm included in the program.  The fourth region of interest 









Table 4-3:  Experimental flow rates used to assess inter- and intraobserver variability.  
Data was compiled at these flow rates, which represent a mid-range rate of 
flow for each simulated vessel, at 160 and 200 mm FOV (n = 12).   
 
 










Statistical Analysis: Bland and Altman Plots and Coefficient of Variance 
  
 In order to assess the resulting data statistically, two statistical methods were 
used: the Bland and Altman method and the coefficient of variance.   
 Bland and Altman plots are used to assess the agreement between two 
measurement techniques and are specifically used when comparing a new method against 
one that is established [17, 96].  As stated by Bland and Altman, it is often misleading 
and inappropriate to evaluate clinical results using correlation coefficients or regression 
analysis [97].  In this experiment, the experimental flow rates provided in Table 4-1 are 
defined as the established method, while the experimental flow rates calculated from each 
region of interest (magnitude, phase, automatic) are defined as the new technique.  This 
method plots the difference between the results of the two methods against the average of 
the two methods, as shown in the example plot in Figure 4-7.  The differences may be 
plotted as a numerical difference, as a percent of the averages, or as a ratio.  For the 
purposes of this experimental study, the plots will be further presented as both a 
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numerical difference between the two methods and also as a percent of the averages to 
more accurately portray observed differences. 
 As shown in Figure 4-7, the graph displays a scatter diagram of the differences 
plotted against the averages of the two measurements.  Dashed lines are drawn at the 
mean difference and the mean difference (bias) plus or minus two standard deviations of 
all data being compared.  This type of statistical comparison is useful in revealing a 
number of key issues, including a relationship between the differences and the averages, 
systemic bias, and also possible outliers.  Bland and Altman plots are also useful in 
assessing the repeatability of a method.  This may be accomplished by comparing 
repeated measurements using one method on a series of subjects.  The Bland and Altman 
method also provides a quantitative bias.  If this bias is consistent, it may be adjusted for 
by subtracting the mean difference from the resultant measurements using the new 









































Figure 4-7:  Example of a Bland and Altman Plot using the difference between 
 methods.  Other variations of this plot may be used, including the  
 presentation of the difference between methods as a percent, which will be  




A second statistical method was used to evaluate the results from the evaluation 
of materials and also to reinforce the results presented in the Bland-Altman plots.  In the 
described experiments, the coefficient of variance (COV) was used [98].  The coefficient 






































Mean + 2σ 
Mean - 2σ 
Mean Difference  
 
 51
where σ is the standard deviation and µ is the mean of flow data obtained using MRI as 
compared to true flow.  The various coefficients of variance were then compared in order 
to help determine the best material to use in this validation study.  The assurance of 
steady, laminar flow throughout the model and accurate, reproducible flow measurements 
in various points along each channel were reinforced using this statistical method.  All 
COV values are also presented in Chapter V for the high-resolution data, in order to 










 The results of the renal phantom validation study are organized into five sections 
corresponding to the five primary studies performed: (1) a material study exploring the 
results of MRI experiments using glass, plastic, and PVA; (2) a comparison of high-
resolution scans at 160, 200 and 350 mm FOV; (3) the variation in MRI experimental 
results using low-resolution (96 phase encodings) versus high-resolution (192 phase 
encodings) protocol; (4) a multiple-site study comparing image data at three points along 
the simulated vessel; and (5) an experiment studying the effects of  velocity encoding in 
three directions.  
 Based upon statistical data, including the Bland-Altman method and the 
coefficient of variance (COV), it is shown that PVA provides more accurate flow values, 
as opposed to other materials, specifically plastic and glass.  Using a high-resolution 
gradient-echo technique with 192 phase encodings, experiments at 160 and 200 mm FOV 
are shown to be superior to those at 350 mm FOV.  The use of high-resolution scans also 
improved results from previous tests using 96 phase encodings (low-resolution).    The 
multiple-site study resulted in similar data along the length of each channel, while 
velocity profiles illustrated that the flow was steady.  The multiple-site study also 
confirmed the overall reproducibility of results.  Velocity encoding in three directions did 
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not significantly improve data.  The results from each of these experimental studies will 
be further discussed in this chapter. 
 
 
Material Evaluation Using PVA, Plastic, and Glass 
  
 The aim of this study was to investigate the MR velocity data resulting from the 
use of PVA, plastic, and glass when used as vessel wall materials in MRI validation.  
Figure 5-1 displays the experimental flow rate results of the PVA and plastic experiments 
taken simultaneously at 200 mm FOV with no background correction applied as 
compared to true flow obtained using the weight determination method.  Glass data was 
acquired using the same parameters, but in a different set of experiments [93], and is 
therefore not compared in this specific figure.  The statistical test used for this specific 
experimental evaluation was the average COV (Equation 4-5); Figure 5-2 displays these 
results for each material. 
 By comparing the flow data acquired through the plastic tubing and comparing it 
to the true flow identity line in Figure 5-1, it is shown that the plastic data generally 
deviates more from the true flow rate values as compared to the PVA data, although some 
points representing plastic flow are more accurate than others.  Figure 5-2 indicates the 
same results, as the average COV of PVA is consistently less than that of both plastic and 
glass.  Plastic data deviates the most at a channel diameter of 4.76 mm, followed by 3.18 
mm, suggesting increased difficulty in accurately defining the vessel wall at smaller 









































































Figure 5-1: Flow rate data obtained from PVA and plastic at the 200 mm FOV with no 
background correction applied.  These results were obtained from the 
following channels: 3.18, 4.76, and 7.94 mm.  As shown, the plastic data 













































Figure 5-2: Average COV results calculated from the image data acquired using PVA, 
plastic, and glass at the 200 mm FOV.  The average COV of PVA is 
consistently less than that of the two supplementary materials studied.
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As shown in Figures 5-1 and 5-2, PVA consistently provides more accurate 
(Figure 5-1) and more precise (Figure 5-2) velocity images as compared to plastic and 
glass.  The average difference between each individual measurement was also calculated 




Comparison of High-Resolution Scans: 160, 200 and 350 mm FOV 
 
  This section will present the results obtained from the high-resolution scans (192 
phase encodings) at 160, 200, and 350 mm FOV.  For each flow rate tested, six sets of 
data are presented, based upon each region of interest as defined in Chapter IV, with and 
without background correction.  In the case of the high-resolution scans, four scans sets 
were unreadable at all fields of view.  The highest flow rates for the simulated channels 
measuring 3.18 and 4.76 mm (764.94 and 864.22 ml/min, respectively) provided 
extremely poor results due to velocity aliasing, which were subsequently not used in the 
analysis.  Wraparound artifact, including velocity aliasing, will be further discussed in the 
next chapter.  For the two highest flow rates at 7.94 mm (896.50 and 979.08 ml/min), the 
FLOW program could not read the velocity information in the images.  This resulted in 
thirty-two data sets available for statistical analysis (n = 32) for each region of interest 
defined for the 160 and 200 mm FOV.  It is also important to note that the automatic 
contour detection algorithm (ROI 3) was unable to determine the vessel boundary for the 
second-highest flow rate for the 3.18 mm channel (531.19 ml/min) at the 350 mm FOV 
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(n = 31 for the ROI 3 data sets).  These issues will also be further discussed in Chapter 
VI: Discussion.  For each flow rate, all six points (ROI 1, ROI 2, ROI 3, BG ROI 1, BG 
ROI 2, AND BG ROI 3) are shown, with the exception of the second-highest rate 
obtained using the 3.18 mm channel.  In these figures, many of the resulting MRI flow 
rates are exceedingly similar in value, making it somewhat difficult to distinguish all six 
points in certain cases.  Figures 5-3 through 5-5 display the experimental flow rates 
calculated using MRI techniques as compared to true flow rates found using the weight 
determination method.  In each of these figures, the magnitude image contour is defined 
as ROI 1, the phase image contour as ROI 2, and the automatic contour as ROI 3.  “BG” 
denotes that background subtraction has been applied to the data series.   
When comparing Figures 5-3 and 5-4, it is difficult to notice a significant 
difference in data between the 160 and 200 mm FOV; both sets of data appear relatively 
accurate as compared to true flow rate values.  However, it is noticeable how the flow 
rate data generally becomes more scattered and less comparable to true flow when the 
350 mm FOV is used (Figure 5-5).  In order to accurately analyze this data, Bland-
Altman plots were used to assess the differences statistically.  The correlation coefficients 
for each ROI when used at each FOV are provided in Table 5-1.  All correlation 
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Figure 5-3: Flow rate data obtained from high-resolution experiments at the 160 mm 
FOV as compared to the true flow rates calculated using the weight 
determination method.  All flow rates presented here span the entire range of 
simulated vessels (n = 32).  The terms in the legend correspond to the 
following: magnitude image contour (ROI 1); phase image contour (ROI 2); 
and automatic contour (ROI 3).  “BG” denotes that background subtraction 












Figure 5-4: Flow rate data obtained from high-resolution experiments at the 200 mm 
FOV as compared to the true flow rates calculated using the weight 
determination method.  All flow rates presented here span the entire range of 
simulated vessels (n = 32).  The terms in the legend correspond to the 
following: magnitude image contour (ROI 1); phase image contour (ROI 2); 
and automatic contour (ROI 3).  “BG” denotes that background subtraction 
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Figure 5-5: Flow rate data obtained from high-resolution experiments at the 350 mm 
FOV as compared to the true flow rates calculated using the weight 
determination method.  All flow rates presented here span the entire range of 
simulated vessels (n = 32), except for ROI 3 and BG ROI 3, where n = 
31.The terms in the legend correspond to the following: magnitude image 
contour (ROI 1); phase image contour (ROI 2); and automatic contour (ROI 
3).  “BG” denotes that background subtraction has been applied to the data 
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Table 5-1: Correlation coefficients calculated for each ROI based upon the data presented  











 Using the Bland-Altman statistical technique, plots were prepared for each region 
of interest analyzed using each particular field of view.  Each plot is presented in 
Appendix A (Figures A-1 through A-18).  A summary of the information extracted using 
the Bland-Altman method is provided in Table 5-2.  Using this information, the biases 
and standard deviations (SD) were compiled for each ROI, and are shown in Figures 5-6 
through 5-11.  
 When using the magnitude border, or ROI 1, the best results were obtained when 
using the 160 mm FOV, while significant deviation from true flow existed when using 
the 350 mm FOV (Figure 5-6).  For the phase border (ROI 2), the 200 mm FOV provided 
the most accurate results, while the 350 mm FOV continued to result in significant 
deviation (Figure 5-7).  The same observations were made for the automatic border (ROI 
3), shown in Figure 5-8.  When applying background correction, the 160 mm FOV 
continued to provide the most accurate results for ROI 1; however, the background 
subtraction improved the data at the 350 mm FOV (Figure 5-9).  In terms of applying  
160 mm 200 mm 350 mm
ROI 1 0.9842 0.9770 0.9716
ROI 2 0.9840 0.9849 0.9500
ROI 3 0.9844 0.9869 0.8540
BG ROI 1 0.9828 0.9754 0.9747
BG ROI 2 0.9830 0.9825 0.9634
BG ROI 3 0.9797 0.9836 0.8477
FOV
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background correction to ROI 2 and ROI 3, no significant changes were observed, as the 
160 and 200 mm FOV provided similar results and the 350 mm FOV provided the 
poorest results (Figures 5-10 and 5-11).  Overall, throughout all cases, it was extremely 
difficult to make an exact determination of which field of view was most accurate: the 
160 or 200 mm FOV.  Thus, a Bland-Altman test was performed comparing the 
combined data sets of ROI 1 (magnitude border) and ROI 2 (phase border) at the 160 and 
200 mm FOV to true flow values.  These plots are presented in Figures 5-12 and 5-13. 
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Table 5-2:  Various quantitative results extracted from the Bland and Altman plots shown 
in Appendix A (Figures A-1 through A-18).  The bias is calculated by finding 
the mean difference between methods, and may be used to adjust results 
obtained using a new clinical method based on a more established one.  Based 
on the assumption of a normal distribution, the majority of data points (95%) 
will lie within two standard deviations (SD) of the mean.  The upper and 
lower percent differences display the difference between methods as a percent 
of the averages.  The terms in the table correspond to the following: 
magnitude image contour (ROI 1); phase image contour (ROI 2); and 
automatic contour (ROI 3).  “BG” denotes that background subtraction has 




Bias - 2 SD + 2 SD Lower % Upper % 
(mL/min) (mL/min) (mL/min) Difference Difference
160 FOV
ROI 1 -0.894 -64.134 62.346 -6.39 11.69
ROI 2 4.459 -59.845 68.763 -6.28 11.88
ROI 3 -10.413 -73.185 52.359 -9.67 7.19
BG ROI 1 6.554 -60.181 73.290 -4.78 10.25
BG ROI 2 11.554 -54.146 77.254 -5.11 9.98
BG ROI 3 -3.508 -77.214 70.199 -10.61 8.37
200 FOV
ROI 1 -0.166 -76.383 76.051 -10.55 11.36
ROI 2 6.262 -55.923 68.447 -8.41 11.05
ROI 3 -5.254 -62.811 52.304 -9.03 8.60
BG ROI 1 7.011 -72.891 86.912 -9.31 11.44
BG ROI 2 12.817 -53.905 79.538 -9.41 13.14
BG ROI 3 0.005 -65.320 65.329 -11.23 9.00
350 FOV
ROI 1 -10.098 -94.993 74.798 -16.45 22.74
ROI 2 1.356 -110.958 113.669 -15.63 23.50
ROI 3 -1.617 -90.610 87.376 -10.79 29.25
BG ROI 1 5.434 -74.543 85.411 -6.89 17.48
BG ROI 2 13.453 -82.833 109.739 -5.88 27.24


























Bias - 2 SD + 2 SD
 
Figure 5-6: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the magnitude border (ROI 1) at 
160, 200, and 350 mm FOV and corresponds to the data presented in Table 
5-2.  The 160 mm FOV proved to be the most accurate parameter in this 






















Bias - 2 SD + 2 SD
 
Figure 5-7: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the phase border (ROI 2) at 160, 
200, and 350 mm FOV and corresponds to the data presented in Table 5-2.  
The 200 mm FOV proved to be the most accurate parameter in this case, 



























Bias - 2 SD + 2 SD
 
Figure 5-8: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the automatic border (ROI 3) at 160, 
200, and 350 mm FOV and corresponds to the data presented in Table 5-2.  
The 200 mm FOV proved to be the most accurate parameter in this case, 






















Bias - 2 SD + 2 SD
 
Figure 5-9: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the magnitude border with 
background correction (BG ROI 1) at 160, 200, and 350 mm FOV and 
corresponds to the data presented in Table 5-2.  The 160 mm FOV proved to 





















Bias - 2 SD + 2 SD
 
Figure 5-10: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the phase border with background 
correction (BG ROI 2) at 160, 200, and 350 mm FOV and corresponds to 
the data presented in Table 5-2.  In this case, the 160 and 200 mm FOV 























Bias - 2 SD + 2 SD
 
Figure 5-11: Graphical comparison of data analysis using the Bland-Altman method.  The 
data presented here was acquired using the automatic border with 
background correction (BG ROI 1) at 160, 200, and 350 mm FOV and 
corresponds to the data presented in Table 5-2.  The 200 mm FOV proved to 









































Figure 5-12: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 64).  This plot corresponds to 


































Figure 5-13: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 64).  This plot corresponds to 




Based upon the statistical results presented in Table 5-2 and Figures 5-6 through 
5-11, it is apparent that using the 350 mm FOV results in data characterized by 
significantly more deviation than those resulting from the use of the 160 or 200 mm 
FOV.  It is also shown in these results that the 160 and 200 mm FOV are comparable in 
terms of the data they provide.  Significant differences in MRI flow rates do not result 
from the use of these two different protocols.  Quantitatively, as shown in Figures 5-12 
and 5-13, the biases for the 160 and 200 mm FOV are 1.782 and 3.048 ml/min, 
respectively.  The 95% limits of agreement were calculated to range from –61.704 to 
65.269 ml/min for the 160 mm FOV, while the 200 mm FOV values ranged from –
66.245 to 72.341 ml/min.  These statistics shown that a significant difference is not 
observed when using the 200 mm FOV, as opposed to the 160 mm FOV.  In order to 
further analyze data sets, the average COV was calculated for each field of view and each 
contour at the 160 and 200 mm FOV.  These results are presented in Figures 5-14 and 5-
15. 
 In Figures 5-14 and 5-15, it is shown that background subtraction, correcting for 
DC phase errors, has no significant positive net effect on the velocity-encoded data.  For 
all average COV values at the 160 and 200 mm FOV, only background correcting the 
phase contour at the 160 mm FOV results in the MRI data being closer in value to the 
true flow rates.   In terms of reducing the amount of bias, using background subtraction 
































Figure 5-14: Average COV results calculated from the image data acquired using the 160 
mm FOV.  Background correction (BG) does not improve the results and 





























Figure 5-15: Average COV results calculated from the image data acquired using the 200 
mm FOV.  Background correction (BG) has no positive effect on this data, 
as all ROIs are negatively affected and vary more from true flow.
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 Because manual definition was required for border determination in the 
magnitude (ROI 1) and phase (ROI 2) maps, a potential source of data variability existed.  
For the six flow rates examined in the inter- and intraobserver studies (Table 4-3), data 
was processed independently by two investigators and compared.  The Bland-Altman 
statistical method was used to analyze these data, and excellent agreement was found 
between the two observers, and also in the intraobserver study.  Using two observers, 
which were blinded, the bias was found to be -0.692 ml/min and –1.567 with the 95% 
limits of agreement ranging from -21.181 ml/min to 19.798 ml/min and –17.274 ml/min 
to 14.141 ml/min for the 160 and 200 mm FOV, respectively (n = 12) (Figure A-19 and 
A-20).  This corresponds to percent differences ranging from –3.193% to 2.571% for the 
160 mm FOV and –2.248% to 2.287% for the 200 mm FOV.  For the intraobserver study 
(n = 12) the bias resulted in -4.621 ml/min with the 95% limits of agreement ranging 
from -17.249 to 8.008 ml/min for the 160 mm FOV (Figure A-21).  For the 200 mm 
FOV, the bias was calculated to be -0.903 ml/min with the 95% limits of agreement 
ranging from -14.705 to 12.899 ml/min (Figure A-22). 
 
 
Low-Resolution Scan Comparison: 160, 200 and 350 mm FOV 
 
In order to demonstrate if an increase in the number of phase encodings makes a 
significant difference in resulting data, low-resolution scans (96 phase encodings) were 
also performed during this validation study.  This subsection will present the results 
obtained from the low-resolution scans at the 160, 200, and 350 mm FOV.  Because 
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background correction was shown to have no significant positive effect on the flow data, 
only the data that has not been background-corrected will be presented for this 
experiment.  Again, the data is obtained from each region of interest defined in the 
images as described in Chapter IV.  The same four scans that provided poor images in the 
high-resolution data also presented issues with the low-resolution data, indicating that 
true flow values may have been the cause of error.  This subsequently resulted in thirty-
two data sets available for statistical analysis (n = 32) for each region of interest.  A 
summary of the information extracted using the Bland-Altman method to analyze the 
low-resolution data is provided in Table 5-3, while corresponding Bland-Altman plots are 
provided in Appendix A (Figures A-23 through A-31).  A graphical comparison of the 
low-resolution data and high-resolution data for each field of view is provided in Figure 
5-16 (ROI 1), 5-17 (ROI 2), and 5-18 (ROI 3).  For the magnitude and phase borders, 
variability in the low-resolution data increased as the field of view increased (Figures 5-
16 and 5-17).  When using the automatic border, low-resolution data was more 
comparable to high-resolution data at the 160 and 200 mm FOV, while increased 











Table 5-3:  Various quantitative results extracted from the Bland and Altman plots shown 
in Figures 5-26 through 5-35 using low-resolution protocol (96 phase 
encodings).  A brief description of each of these statistical parameters is 
provided with Table 5-2.  When comparing the values in this table with those 
in Table 5-2, it is apparent that high-resolution protocol (192 phase encodings) 





Bias - 2 SD + 2 SD Lower % Upper % 
(mL/min) (mL/min) (mL/min) Difference Difference
160 FOV
ROI 1 11.804 -83.936 107.543 -9.42 34.73
ROI 2 33.097 -77.364 143.558 -11.02 35.52
ROI 3 -27.310 -113.033 58.413 -20.13 15.21
200 FOV
ROI 1 32.806 -97.695 163.306 -10.94 47.48
ROI 2 57.307 -131.192 245.267 -9.68 61.43
ROI 3 -39.897 -141.624 61.831 -19.22 26.30
350 FOV
ROI 1 173.082 -40.846 387.010 7.12 80.23
ROI 2 158.894 -120.122 437.910 -9.89 85.13
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Figure 5-16: Graphical comparison of high-resolution (192 phase encodings) and low-
resolution (96 phase encodings) protocol obtained using the Bland-Altman 
method.  The data presented here was acquired using the magnitude border 
(ROI 1) at the 160, 200, and 350 mm FOV and corresponds to the data 
presented in Table 5-3.  The amount of variability between low- and high-





















Bias - 2 SD + 2 SD
 
Figure 5-17: Graphical comparison of high-resolution (192 phase encodings) and low-
resolution (96 phase encodings) protocol obtained using the Bland-Altman 
method.  The data presented here was acquired using the phase border (ROI 
2) at the 160, 200, and 350 mm FOV and corresponds to the data presented 
in Table 5-3.  The amount of variability between low- and high-resolution 




























Bias - 2 SD + 2 SD
 
Figure 5-18: Graphical comparison of high-resolution (192 phase encodings) and low-
resolution (96 phase encodings) protocol obtained using the Bland-Altman 
method.  The data presented here was acquired using the automatic border 
(ROI 3) at 160, 200, and 350 mm FOV and corresponds to the data 
presented in Table 5-3.  In this case, the low-resolution data is comparable at 






As shown in Table 5-3 and Figures A-23 through A-31, low-resolution protocol 
using 96 phase encodings produces data with a considerable amount of bias and 
variability when compared to true flow values.  This data suggests that high-resolution 
protocol using 192 phase encodings is an improved technique providing more accurate 
data, shown graphically in Figures 5-16 through 5-18. 
Figures 5-19 and 5-20 display the Bland-Altman plots using the percent 
difference method.  These figures more accurately portray the significant differences 
observed using a lower resolution protocol, and do not show the 95% limits of agreement 
as the data points are shown as a percent of the corresponding averages.  These figures 
emphasize the differences observed between low-resolution MRI data and true flow 
based upon each flow rate.  This characteristic resulted in some interesting observations.  
When using 96 phase encodings, velocity-encoded data is consistently less accurate at 
lower flow rates (< 500 ml/min).  This was consistent across all low-resolution data sets. 
For the low-resolution data, the absolute bias values were consistently greater 
than those observed using high-resolution protocol (Figures 5-16 through 5-18).  The 
automatic detection algorithm also underestimated the contour of the simulated vessel 
throughout these experiments.  Overall, MRI data varied significantly more using the 





























Figure 5-19: Bland and Altman plot displaying the difference between true flow values 
and MRI data as a percentage using low-resolution protocol (96 phase 
encodings).  This figure specifically shows the extreme deviation from true 
flow, especially at lower flow rates (< 500 ml/min).  Data presented here is 































Figure 5-20: Bland and Altman plot displaying the difference between true flow values 
and MRI data as a percentage using low-resolution protocol (96 phase 
encodings).  This figure also shows the extreme deviation from true flow, 
specifically at lower flow rates (< 500 ml/min).  Data presented here is from 




 In order to ensure that the flow characteristics during the validation study were 
laminar and fully-developed, visually-defined perpendicular planes were imaged at three 
different points along each vessel for each scan set.  The first scan plane is centered along 
the phantom, and this data has been previously presented as the 200 mm FOV high-
resolution data.  The second and third scan planes were used to evaluate flow along the 
length of each simulated vessel at the 200 mm FOV.  A schematic of the scan planes and 
their orientation is provided in Figure 5-21.  These scans were performed at the 200 mm 
FOV using 192 phase encodings (high-resolution).  The Bland-Altman test was used to 
test the statistical accuracy of this method for the magnitude and phase borders by 
combining the data acquired at sites 2 and 3 and comparing it against data from site 1 (n 
= 50 for each).  Agreement was found to be close over the flow range tested for both 
regions of interest observed, as shown in Figures 5-22 and 5-23.  The bias calculated 
using the data from the magnitude border (ROI 1) was found to equal 4.784 ml/min, 
while the 95% limits of agreement equaled -27.288 to 36.856 ml/min (Figure 5-22).  For 
the phase border (ROI 2), the bias was equivalent to 0.372 ml/min, while the 95% limits 
of agreement were found to equal -18.959 to 19.702 ml/min (Figure 5-23).  The average 
COV was also calculated for these observations and was recorded as 1.04% and 1.93% 
for ROI 1 and ROI 2, respectively.  This data also exhibits the overall reproducibility of 
the method.  In addition to the inter- and intraobserver studies, the multiple-site test 
shows that it is possible to obtain both accurate and reproducible flow data.  The biases 

















Figure 5-21: Schematic showing visually-defined perpendicular planes used to capture 
velocity-encoded phase images in this phantom validation study.  The first 
scan plane is centered along the phantom, and this data is presented as the 
200 mm FOV high-resolution data.  The second and third scan planes were 

































Figure 5-22: Bland and Altman plot displaying the difference between sites 2 and 3 as 
compared to site 1 (Figure 5-21).  This plot corresponds to the manual 

































Figure 5-23: Bland and Altman plot displaying the difference between sites 2 and 3 as 
compared to site 1 (Figure 5-21).  This plot corresponds to the manual 
contour drawn in the phase image (ROI 2) at the 200 mm FOV. 
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The flow characteristics resulting from this experiment were also analyzed using 
velocity profiles generated by the FLOW program for each separate scan over the cardiac 
cycle (16 phases for high-resolution data).  Plots were observed as the analysis was 
completed for each data set to check for irregularity in flow characteristics.  Across the 
cardiac cycle, all flow rates were within 2 ml/s of each other, most having a difference of 
less than 0.5 ml/s.  The data presented in this section suggest that steady, laminar flow 
was present throughout the experimental study, which further agrees with the Reynolds 
number calculations performed at each flow rate for each simulated vessel using Equation 
(4-2).  The Reynolds numbers are provided in Table 5-4, with each corresponding flow 
rate listed directly below the respective Reynolds number.  
Although a precise range cannot be quantified for whether flow is classified as 
laminar or turbulent, it is appropriate for general purposes to describe flow in a pipe, or 
round tube, as laminar if the Reynolds number is less than 2100 [99].  If the Reynolds 
number is greater than 4000, turbulent flow exists, with the region in between these two 
values defined as transitional.  In the transitional state, flow may switch between laminar 
and turbulent flow.  However, since the greatest Reynolds number in this validation study 
is 1460.75, it is shown that only laminar flow was present in these experiments 



















Table 5-4:  Reynolds numbers resulting from experimental flow rates measured using 
the weight determination method, which are shown in parentheses below 
each corresponding Reynolds number.  The Reynolds numbers listed below 
were calculated using Equation (4-2) and are all within the laminar range, as 




3.18 4.76 6.35 7.94 9.52 11.11
235.55 354.03 321.72 364.52 338.68 378.85
(123.35) (278.09) (336.95) (477.22) (532.07) (694.37)
462.38 524.15 437.24 437.75 449.95 434.65
Reynolds (242.13) (411.72) (457.93) (573.09) (706.87) (796.64)
Number (Re) 721.76 649.32 624.90 528.10 506.61 464.62
(377.96) (510.04) (654.48) (691.37) (795.88) (851.56)
759.44 840.55 655.06 601.26 514.46 501.51
(Flow Rate) (397.69) (660.25) (686.06) (787.15) (808.22) (919.18)
(mL/min) 1014.37 982.02 710.26 684.79 613.88 551.30
(531.19) (771.37) (743.88) (896.5) (964.4) (1010.44)
1460.75 1100.22 830.60 747.87 727.02 648.95
(764.94) (864.22) (869.91) (979.08) (1142.15) (1189.41)
Channel Diameter (mm)
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Velocity Encoding in Three Directions 
 
For this experiment, velocity was encoded in all three orthogonal planes (RL, AP, 
FH) to detect any deviations in flow and to observe if this technique provided more 
accurate results.  These scans were performed using a field of view of 240 mm x 240 mm 
(240 mm).  Each scan was then reconstructed and individually analyzed using the same 
method as previously described.  A total of twenty-four reconstructed image sequences 
were readable and subsequently analyzed using this protocol.  Table 5-5 provides a 
summary of these results using the Bland and Altman method.   
When comparing these results to those in Table 5-2, specifically at the 200 mm 
FOV, the amount of bias is comparable; however, the 95% limits of agreement are 
greater in both directions (± 2 SD) all regions of interest defined.  This is shown 
graphically in Figure 5-24.  It is interesting to note that the automatic detection algorithm 
(ROI 3) provided the best results for this technique, although it was not significantly 
better than the manually-defined magnitude and phase borders.  The bias was only 
















Table 5-5:  Quantitative summary resulting from experiment with velocity encoded in 
three directions.  A field of view of 240 mm was used in this protocol.   The 
magnitude (ROI 1), phase (ROI 2), and automatic (ROI 3) borders were 
analyzed using this technique.  The automatic detection algorithm most 
accurately analyzed the velocity data encoded in the phase-velocity images for 
this protocol, but not by a significant amount. 
 
Bias - 2 SD + 2 SD Lower % Upper % 
(mL/min) (mL/min) (mL/min) Difference Difference
240 FOV
ROI 1 -4.699 -112.602 103.204 -11.65 9.92
ROI 2 4.556 -100.582 109.694 -11.51 18.43
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Figure 5-24: Graphical comparison of high-resolution protocol at the 200 mm FOV with 
protocol velocity-encoded in all three orthogonal planes (240 mm FOV).  It 
is shown that this technique is not useful as compared to high-resolution 
protocol, as increased variability is observed with all image contours at the 
240 mm FOV.
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Summary of Findings 
  
Based upon statistical analysis, including the Bland-Altman method and the 
coefficient of variance (COV), a number of key results have been presented.  It has been 
shown that PVA is a superior phantom material to be used as an MRI quality control 
phantom.  By using a high-resolution gradient-echo technique with 192 phase encodings, 
experiments at the 160 and 200 mm FOV are shown to be superior to those at the 350 
mm FOV.  It is also shown that these results are more accurate than low-resolution 
protocol using 96 phase encodings.   Inter- and intraobserver results were excellent, 
ensuring repeatability of the method, especially at the 200 mm FOV.  The multiple-site 
study, which used images acquired at three locations along the simulated vessel, showed 
similar results along each channel.  This suggested fully-developed and laminar flow, 
which was also the result of the Reynolds number calculations.  The multiple-site study 
also reinforced the results of the inter- and intraobserver studies, showing that this MRI 
flow measurement method is both accurate and reproducible.  The observation of velocity 
profiles also illustrated that the flow was steady.  Velocity encoding in three directions 
did not significantly improve data, further suggesting that high-resolution protocol using 
192 phase encodings is the most accurate technique for the purposes of the clinical 












In this chapter, the results presented in Chapter V will be discussed and the 
significance of each finding will be presented.  A number of experiments were performed 
during this study to determine the most accurate protocol to be used in RBF 
quantification. The tolerance of the MRI flow measurement method under controlled 
steady-flow conditions, which partially simulated renal arterial blood flow, was also 
evaluated.  This discussion focuses on a variety of MRI parameters and how they have 
been applied in these experiments to correctly capture flow through a simulated vessel. 
 
 
Motivation for the Study 
 
 The long-term goals of the CRISP study include the capacity to more fully 
understand how MRI may be used to assess renal circulation.  It has been shown that the 
hemodynamic parameters measured in the renal arteries correlate strongly with the 
anatomical and functional indicators of ADPKD severity [19].  In the short-term, the 
outcome of the present validation study may be applied to clinical investigations, 
resulting in the acquisition of more accurate RBF data.  This will further allow clinicians 
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to understand the processes involved that cause the correlation between RBF and other 
indicators of ADPKD severity.  By having a more complete understanding of these 
processes, more effective diagnostic and treatment plans may be developed. 
 
 
Material Evaluation Using PVA, Plastic, and Glass 
 
As stated in Chapter V, the average coefficient of variation (COV) determined 
using PVA data was consistently less than that of plastic and glass (-9.56% and -3.62% 
from COV values for plastic and glass, respectively; see Figure 5-2).  Serious 
inconsistencies were observed between the ROI data sets at a single flow rate along the 
entire range of flow rates observed when using plastic (Figure 5-1) due to various factors.  
Increased variation between individual measurements performed using each material, as 
compared to true flow values (Figure 5-1), suggests that there exists more sensitivity to 
lumen border determination when the surrounding area is air, as the plastic data was 
acquired in this type of environment.  During the PVA and glass experiments, the 
surrounding environment included PVA and water, respectively.  This implies that when 
the object being imaged is surrounded by air, a low MRI signal intensity results at the 
lumen boundary, which contributes to velocity estimation errors.  PVA and water 
produce an improved signal, due to the basis of NMR and the inherent magnetic 
properties that these materials possess as a result of their elemental makeup.  PVA is 
comprised of carbon, hydrogen, and oxygen, which are all NMR active elements, and 
therefore provide a signal when scanned using MRI.  Figure 6-1 displays a comparison of 
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plastic and PVA data acquired during this study, as compared to in vivo tissue found in 











Figure 6-1: In vitro and in vivo breath-held phase-velocity encoded MRI scans.  The 
plastic material in (A) was found to perform less like the in vivo tissue in (B) 




As shown by the quantitative data presented in Figures 5-1 and 5-2, as well as the 
MRI images displayed in Figure 6-1, models using PVA present more realistic vessel 
lumen than plastic or glass models.  A distinct ring is present around the flow region in 
both plastic (Figure 6-1) and glass models, resulting from the materials’ magnetic 
properties: plastic and glass are incapable of providing a signal comparable to the 
resultant PVA signal.  The PVA model displays a more indefinite wall, as a result of the 
signal that PVA provides, and is more realistic as compared to vessel lumen observed in 
vivo.  It is also important to note that partial volume effects did not seem to be as 
prevalent when using PVA.  The partial volume effect phenomenon occurs because each 
voxel in the image may represent more than one tissue type, or in this case, type of 
material.  The image value of a particular voxel reflects the average value over the object, 
A B C
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which may be skewed when rapid changes occur across the object.  As PVA provides a 
stronger MRI signal, these changes are not as drastic when this type of model is used, 
resulting in more correct data less prone to partial volume effects. 
PVA is also mechanically comparable to vessel lumen and shares many of the 
same magnetic properties [25].  These properties are determined by the cross-linking that 
occurs during the freeze-thaw cycles.  During the freezing process, crystal nuclei are 
formed, which form into larger crystals during the thaw cycle.  The crystals act as cross-
linking sites for the polymer, which increase in size and number with each cycle, 
resulting in the rubber-like mold formed in this study.   
Chu and Rutt [25] focused on reproducing the elastic modulus of porcine aortas 
using PVA, in addition to two magnetic properties during their experiment: the T1 and T2 
relaxation times.   Following each pulse, the longitudinal magnetization (Mz) is converted 
into the transverse magnetization (Mxy), which is not oriented along the B0 field.  When 
the pulse is turned off, the longitudinal magnetization returns to its initial state.  The 
recovery time of the longitudinal magnetization is referred to as the T1 relaxation time.  T2 
relaxation is defined as the decay of transverse magnetization immediately following 
each pulse when the longitudinal magnetization is completely converted into transverse 
magnetization (Mxy).   
Chu and Rutt were able to obtain the range of healthy porcine aortic T1 and T2 
relaxation times using between two and five freeze-thaw cycles and two to three freeze-
thaw cycles, respectively.  It is important to note that the PVA cryogel used in the present 
study was made from a solution containing 30% PVA and 70% water.  Lower PVA 
concentrations (specifically 15% by weight), as discussed by Chu and Rutt, result in 
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models that exhibit superior imaging properties, but are also more fragile.  During initial 
experimentation in this renal validation study, the cryogel with a concentration of 20% 
PVA had difficulty withstanding its own weight.  However, in smaller vessel model 
experiments, lower PVA concentrations may be used.  By exhibiting some of the same 
important mechanical and magnetic properties as compared to porcine aortas, PVA is 
shown to be a superior phantom material as compared to plastic and glass.  This 
statement is further confirmed by the statistical analysis presented in Figures 5-1 and 5-2.    
 
 
Comparison of High-Resolution Scans: 160, 200, and 350 mm FOV 
 
Field of View 
  A large portion of the present study focuses on the field of view (FOV) 
parameter.  The FOV is the physical length over which the image extends in both the 
frequency and phase-encoding directions.  In various applications, the image will be 
square so that a single value for the FOV is specified, which is the case in this study.  
However, a rectangular FOV may also be used.  Data was taken at three different fields 
of view in these experiments using the high-resolution protocol: the 160 mm, 200 mm, 
and 350 mm FOV (all square).  When observing the data presented in Chapter V (Table 
5-2, Figure 5-6 through 5-11), it becomes apparent that minimization of FOV is 
important in acquiring accurate MRI velocity data to increase data quality and resolution.  
At the 350 mm FOV, data was more scattered and less accurate as compared to data 
obtained using the 160 and 200 mm FOV.   For example, a comparison of the Bland and 
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Altman plots using the phase border at the 160 and 350 mm FOV shows an increase in 
disagreement with the corresponding increase in FOV (Figure 6-2).  At the 160 mm FOV, 
the resultant bias is 4.459 mL/min, while the 95% limits of agreement are -59.845 and 
68.763 mL/min.  For the 350 mm FOV, the bias is 1.356 mL and the 95% limits of 
agreement range from -110.958 to 113.669 mL/min for the same region of interest.   
Although the bias is slightly less, the 95% limits of agreement are significantly greater.  
This is more accurately portrayed by the lower and upper percent differences, which are 
equivalent to -15.63 and 23.50 for the 350 mm FOV and -6.28 and 11.88 for the 160 mm 
FOV.  The same pattern was seen throughout these experiments, with the 350 mm FOV 
data being consistently worse than the results obtained for both the 160 and 200 mm 
FOV.  Similar results were obtained for the 160 and 200 mm FOV; however, this is to be 
expected, as only a 40 mm difference exists along each length between the two fields of 
view.  The 160 mm FOV did provide slightly better results than the 200 mm FOV, again 
suggesting that minimization of FOV is important for this study.  However, it is 
important to note that the biases for the 160 and 200 mm FOV were 1.782 and 3.048 
ml/min, respectively, with very similar 95% limits of agreement.  This difference in the 
bias of only 1.266 ml/min suggests that using a 200 mm FOV as opposed to a 160 mm 
FOV should not result in significantly less accurate flow data.  As the FOV is decreased, 
pixel size increases, allowing for more accurate determination of the vessel contour.  
However, using a 160 mm FOV instead of a 200 mm FOV does not significantly improve 





































































Figure 6-2: Comparison of Bland-Altman plots using the phase border using (A) the 160 
mm FOV and (B) the 350 mm FOV.  The 95% limits of agreement for the  
350 mm FOV data were larger than the 160 mm FOV, indicating that 





 The differences observed in the data are attributed to spatial resolution.  As the 
FOV was increased in the present study, the spatial resolution of the images decreased, 
which has been attributed to partial volume effects [18].  This change resulted in data 
with increased deviation from true flow values, as described in previously.  By 
minimizing the field of view, while ensuring that the entire vessel area is captured, more 
precise flow measurements may be obtained.   
Although a larger area of the anatomy is excited when using the 350 mm FOV, 
the object of study may be too small to accurately determine the lumen border.  
Throughout the image analysis process, the MRI images taken using the 350 mm FOV 
had to be magnified in order to determine the lumen border using the “zoom” tool in the 
FLOW software program.  This resulted in a blurred image, causing additional difficulty 
(A)  (B) 
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in lumen border determination.  With improved automatic algorithms, this issue may be 
resolved.  At the 350 mm FOV, the automatic border provided slightly better results as 
compared to the magnitude and phase borders (Table 5-2), suggesting that with larger 
fields of view, a precise automatic algorithm may provide superior data as compared to 
manual determination.  Throughout the experiment, the data resulting from the use of the 
automatic algorithm in the FLOW software program was comparable to both the 
magnitude and phase borders performed manually, although it did not provide as accurate 
results using the 160 and 200 mm FOV, or when artifact was present. 
 
Wraparound Artifact 
 The wraparound phenomenon is also commonly referred to aliasing.  Two types 
of aliasing may occur during the acquisition of MRI scans: frequency aliasing and phase 
aliasing.  This discussion will focus on phase aliasing, or phase wrap, as this artifact was 
observed during post-processing. 
 During MRI acquisition during clinical studies, anatomy outside of the defined 
FOV can be excited by the RF pulses.  Because phase encoding gradients are only scaled 
for the specific FOV being used, these tissues are not properly phase-encoded relative to 
their anatomical position.  When this occurs, the anatomy outside the FOV “wraps” onto 
the opposite side of the image, resulting in a MRI scan where anatomy appears to be in 
the wrong place.  During the 3.18 mm diameter experiment in the present study, this 
phenomenon was observed.  Because the “anatomy” surrounding the channel was simply 
the PVA block, a “black hole” appeared within a number of the phase images; an 












Figure 6-3: Phase image for the 160 mm FOV scan obtained for the 3.18 mm channel 
experiment.  The arrow points to the flow region, which contains the 
wraparound artifact.  This phenomenon is due to the excitation of tissue 
outside the defined FOV boundary, which causes the anatomy to be 
displaced from its actual position.  This image was corrected by properly 
encoding the “unwanted” tissue using the phase-unwrap feature in the 
FLOW software program.  These values are presented in Table 6-1. 
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wraparound artifact became more prominent; however, aliasing was not present in the 
350 mm FOV images until the highest flow rate experiment that provided readable 
images (531.19 mL/min).  This observation may be attributed to increased partial volume 
effects noticed at higher fields of view.  In this experiment, the aliasing present in the 
images is attributed to the values used to define the velocity encoding range.  From the 
resulting data, it appears that the values used were too small to accurately capture 
velocity images.  The velocity encoding values determine the maximum velocity that can 
be correctly measured without causing aliasing.  It is important to note that increasing the 
velocity encoding range ultimately decreases the velocity-to-noise ratio [100]; however, 
it has been determined that because the flow velocities, and thereby the flow rates, are 
integrated over a large number of voxels, increasing the velocity encoding range by a 
realistic amount (50 to 100 cm/s) does not significantly increase the amount of error [18].  
The decrease in velocity resolution may however have an effect on accurately acquiring 
peak flow velocity measurements [18].  This bears a certain degree of importance in the 
application of phase-velocity encoded MRI to ADPKD clinical evaluation, as the ability 
to distinguish between slow-flowing and stagnant blood is diminished with decreased 
resolution.  In hypertensive ADPKD patients, it is important to have the ability to 
differentiate between these two types of flow patterns. 
In order to correct phase wrap, a number of steps may be taken.  A larger field of 
view may be used, presaturation pulses may be applied to the undesired tissue, or the 
unwanted “tissue” may be correctly velocity-encoded [94].  As shown by the 350 mm 
FOV experiments, increasing the field of view seems to hide the phase wrap artifact in 
most cases; however, decreased spatial resolution is again observed and the velocities 
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may not be correct.  For the remaining experiments, the images were correctly phase-
encoded during post-processing.  This was accomplished using the “phase-unwrap” 
feature in the FLOW software program, which is based upon Equation (6-1), 
 
 enccorr vvv 2+=  (6-1) 
 
where vcorr is the corrected velocity and venc is the velocity-encoding value used (100 
cm/s in this study).  Table 6-1 shows the values used for each scan used to correct each 
image, and it is important to note that the velocity range is 200 cm/s, or twice the 
velocity-encoding value.  By correctly encoding the images, accurate flow data was 
obtained; however, it is important to note that the automatic border detection algorithm 
built into the software program did not accurately capture the vessel border in these 
affected images.  This is an issue that should be further looked into by software 
programmers, in order to decrease the amount of time required for data analysis while 
also providing accurate velocity and flow results.  Although the images in the present in 
vitro experiment were correctly velocity encoded during analysis, it is important to note 
that the ability to recognize aliasing becomes more difficult using images obtained during 
in vivo clinical exams.  Care should be taken during clinical exams in order to obtain 









Table 6-1: Parameters used to correct wraparound artifact for 3.175 mm simulated 
vessel.  Vmin and vmax are provided for each scan corrected.  It is 
important to note the direct relationship between FOV and the degree of 
aliasing:  as the FOV increases, the degree of phase wrap increases, as well.  
 
Flow Rate (mL/min) FOV (mm) vmin (cm/s) vmax (cm/s)
377.96 160 -76 124
377.96 200 -86 114
397.69 160 -70 130
397.69 200 -79 121
531.19 160 -40 160
531.19 200 -51 149




 The results presented in Table 5-2 show that the background-subtraction method 
does not significantly improve the results, if improvement is observed at all.  This is 
further confirmed in Figures 5-14 and 5-15.  A table summarizing the results shown in 
these figures is provided in Table 6-2.  Although all COV values are within 5 percent, in 
all but one experiment (160 mm FOV, ROI 2), the background subtraction actually 
increased the COV.  Because the PVA mold provides a static signal, it was expected and 
is shown that the data obtained using the background-subtraction method does not 
drastically alter these measurements.  Similar results have been presented in previous 
studies where correcting for DC phase errors did not result in more accurate flow 
measurements [18, 21].  Under in vitro conditions, artifactual phase shifts are at a 
minimum, causing no improvement in results when applying a first-order background 
phase correction algorithm [18].  However, this background-subtraction method may be 
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valuable during in vivo clinical investigations, where other vessels and anatomical 
structures have the capability of producing a more dynamic background signal. 
 The background-subtraction results do show that diffusion through the PVA mold 
was not present, as there is an absence of background velocity.  During certain 
experiments, specifically at high flow rates, leaks occurred at the entry and exit points 
where the Teflon tubing was inserted into the phantom casing and PVA mold.  Although 
this issue was immediately addressed and all efforts were made to prevent leaks, the 
faulty connections between the Teflon tubing and the PVA may be an overall cause of 
error in this validation study.  Flow rates were experimentally measured using the weight 
determination method before and after each set of scans, but not simultaneously.  Efforts 
were also made to obtain the flow rates using digital flow probes.  This method was 
rejected due to the appearance of artifacts during the scans.  Even though a minimum 
number of connections were used throughout the flow loop to prevent leaks and air 
saturation of the glycerin and water solution, leaks often persisted at the highest flow 
rates for each channel diameter, and may contribute to the error observed between the 
















Table 6-2: Resulting COV values between true flow and flow measured using velocity-
encoded MRI (graphically shown in Figures 5-14 and 5-15).  Background 
subtraction actually increased the COV between the true flow MRI flow in 




No BG  BG
160 FOV
ROI 1 2.96 3.33
ROI 2 3.08 3.03
ROI 3 3.11 3.32
200 FOV
ROI 1 3.61 4.07
ROI 2 2.99 3.17






Region of Interest 
 In the high-resolution scans, ROI 2 (the phase contour) provided the most 
accurate results in terms of the lower and upper percent differences when comparing the 
160 and 200 mm FOV data (Table 5-2).  By taking into account the amount of bias 
present, the corresponding data may be altered accordingly, providing more accurate 
MRI flow results.  When the contour is manually traced in the phase image, velocity 
components (in cm/s) are used to outline the region of interest.  In the magnitude image 
(ROI 1), the manual tracing is less quantitatively defined, and as hypothesized, it does not 
provide results with the same amount of accuracy as compared to ROI 2.  Although the 
results obtained with the use of the automatic border detection algorithm are reasonably 
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comparable to the results from the phase image, it is important to note that this method 
provides slightly less accurate results.   
 Throughout this study, it has been discussed how the automatic detection 
algorithm did not perform as well as expected under certain circumstances, specifically 
when artifacts are observed in the images.  Therefore, it is not recommended that the 
same automatic program be used for in vivo studies.  However, other studies have shown 
that certain “in-house” programs have more accurately captured the lumen boundary, 
both in vivo and in vitro [20-21, 54).  Such an algorithm has been applied to flow in the 
ascending aorta as defined by van der Geest et al. [54], in which manual tracing of the 
contours required approximately ten minutes, while only six seconds were required with 
the use of the automated contour detection program.  Inter-and intraobserver variabilities 
were less than two percent for both the manual and the automated methods in this study, 
suggesting a precise automatic algorithm.  The application of a similar automated process 
would enhance the clinical applicability of MR flow velocity mapping to the renal 
arteries.  The use of an automated algorithm may also reduce interobserver variability of 
the multiphase studies, although the error observed between subjects in this study was 
minimal. 
It is also interesting to note the correlation between the FOV and the different 
regions of interest.  As the field of view was decreased, the statistical differences 
observed between ROI 1 (magnitude border) and ROI 2 (phase border) became less 
(Table 5-2).  At the 160 mm FOV, the lower percent difference decreased by only 0.11% 
while the upper percent difference increased by 0.19% when going from ROI 1 to ROI 2.  
This result further shows the increased spatial resolution observed with a decrease in 
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FOV.  As ROI 1 is based more upon the evaluator’s interpretation of the contour, it is 
implied that the increased resolution resulting from the decrease in FOV improves the 
accuracy of the evaluator, as shown by comparing ROI 1 to ROI 2 (Figures 5-6 and 5-7).  
 
 
Low-Resolution Scan Comparison: 160, 200, and 350 mm FOV 
 
 In order to assist in determining the best protocol, low-resolution scans were also 
performed at the same fields of view as in the high-resolution scans.  Changes in protocol 
resulted in flow rate values being closer to the true flow values for the high-resolution 
data acquisition using 192 phase encodings as compared to the low-resolution data, 
which used only 96 phase encodings.  Overall, an increase was observed in all 
quantitative parameters for the low-resolution protocol comprising the Bland and Altman 
plots, including the bias, 95% limits of agreement, and lower and upper percent 
differences (Table 5-3, Figures 5-16 through 5-18).  This assists in showing that an 
increase in the number of phase encodings from 96 (low-resolution) to 192 (high-
resolution) improves the data.  This result was also expected, as less detail exists in the 
phase-encoding direction with each decrease in the number of phase encodings.  
However, the increase in the number of phase encodings to 192 increased the image 
acquisition time from 20 to 30 seconds.  This effect was expected as the total imaging 
time is defined by Equation (6-3), 
 
 Total imaging time = 2 × (TR) × (NSA) × (Number of phase encodings) (6-3) 
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where TR is the relaxation time and NSA is the number of signal averages.  The total 
imaging time is multiplied by two (shown in Equation 6-3) because of the velocity 
encoding.  The scan time increase may have a slight impact on patients undergoing 
clinical investigation.  Because these scans are breath-held, certain individuals will 
experience difficulty having the scans performed.  This includes, but is not limited to, 
individuals who do not have the ability to hold their breath for an extended amount of 
time due to illnesses affecting their respiratory system, small children, and elderly 
patients.  As MRI technology continues to improve, this problem will be addressed, and 
scan times will be reduced while the same, or improved, high-resolution protocol is 
maintained. 
 Based upon the comparison of the low-resolution and high-resolution results in 
this in vitro study, the number of phase encodings in the CRISP protocol was increased in 
order to obtain the most accurate patient data possible.  Although this increased 
acquisition time by 10 seconds, it has been shown through the present phantom study that 





 In order to assess the flow characteristics present in the phantom model, as well as 
the overall reproducibility of the MRI flow measurement method, the multiple-site test 
was performed by scanning the simulated vessels in three sites using three defined planes 
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perpendicular to the direction of flow.  The 200 mm FOV was used for this experiment.  
It was hypothesized that sites 2 and 3 (Figure 5-21), located between the entry and exit 
points and the site 1 of the model, would provide equivalent flow data, based upon the 
entry-length tubing calculations (Equation (4-1)) and the fact that the model did not 
introduce any directional flow changes.  Based upon the results obtained using the Bland-
Altman statistical method, it is shown that the flow in this experiment was fully 
developed.   
 The Bland and Altman plots shown in Figures 5-22 and 5-23 show that ROI 2 
(phase contour) again provides the most accurate results.  The bias for ROI 2 was 0.372 
mL/min, while the bias for ROI 1 (magnitude contour) equaled 4.784 mL/min.  The 95% 
limits of agreement were also closer for ROI 2 than for ROI 1 (-18.959 to 19.702 and  
-27.288 to 36.856, respectively).  These results may have been slightly more accurate if 
the 160 mm FOV was used instead of the 200 mm FOV, based upon earlier discussion in 
this chapter.  However, it is hypothesized that such a change would not have resulted in a 
significant improvement, based upon the results for the 160 and 200 mm FOV high-
resolution data. From the statistical analysis pertaining to the multiple-site experiments, it 
is shown that the flow throughout the model was fully-developed (Figure 5-22 and 5-23).  
Based upon these same results, the overall reproducibility of the MRI flow measurement 
method is also confirmed. 
 Using the FLOW software program, velocity curves were generated as a function 
of time for each data set.  These were observed during post-processing, and as stated 
previously, flow rate measurements were all within 2 mL/s of one another, with the 
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majority of points measuring within 0.5 mL/s.  These velocity profiles suggest that the 
flow was also steady throughout the model for the duration of the experiment.  
 Reynolds numbers were also calculated for each channel diameter at each 
experimental flow rate.  The highest Reynolds number present in the experiment was 
approximately 1461, showing that turbulent flow should not have been present during 
any experiment in this study, as the transition into turbulent flow does not begin until a 
Reynolds number of 2100 for this type of experimental setup.  Three-dimensional 
velocity encoding was used to further investigate this specific flow characteristic.  As 
discussed here, the flow in this experiment may be characterized, as steady, laminar, and 
fully-developed. 
 It is important to note that the described flow characteristics in this model are not 
a truly accurate representation of the flow observed in vivo.  The purpose of this study 
was first to determine and suggest protocol that may be used to obtain accurate blood 
flow measurements during clinical investigation.  In order to do so, a steady and laminar 
flow was used, as the flow rate should be constant throughout the model when observing 
flow with the described characteristics.  Pulsatile flow will be used in later research to 
more accurately represent in vivo flow characteristics. 
 
 
Velocity Encoding in Three Directions 
 
By experimenting with velocity encoding in all three orthogonal directions, it was 
further shown through statistical analysis that the flow in the model was laminar and 
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fully-developed (Table 5-5, Figure 5-24) .  Flow was only present in a single direction, 
and the results were highly comparable to those obtained using the 200 mm FOV, 
specifically the bias values.  The 95% limits of agreement were greater in both the 
positive and negative directions for the 240 mm FOV three-dimensional scan.  This 
increase may be attributed to the increase in field of view.  Although velocity encoding 
does not improve results in this in vitro validation, this technique may be applied to in 
vivo clinical studies, where more complex three-dimensional flow fields may be present.   
 
  
This discussion has presented the effects of altering a number of MRI parameters 
as applied to the range of vessel diameters observed in the renal arteries.  A number of 
experiments were performed during this study to determine the most accurate protocol to 
be used in RBF quantification.  Based upon these results and discussion, a specific 
protocol was formulated to provide the most correct data obtainable using phase-velocity 









In the present study, a number of acquisition parameters were experimentally 
tested to observe their effects on the accuracy of resulting image data using a phantom 
with biomechanical and MR signal properties similar to the properties possessed by aortic 
tissue with a laminar flow profile.  The more closely the materials composing the 
phantom mimic tissue parenchymae with respect to the relevant physical and chemical 
properties, the more valuable the phantom.  As such, various materials were initially 
tested, with PVA being selected as the material of choice based upon its ability to mimic 
vessel properties. The importance of surrounding the simulated vessel with a material 
providing a good MRI signal has been shown, as increased velocity estimation errors 
were observed when the “vessel” under examination was surrounded by air.   This error 
was attributed to a low MRI signal intensity occurring at the lumen boundary.   
It has been shown that certain parameters do not make a significant impact on the 
preciseness of results, such as three-dimensional velocity encoding.  Other parameters, 
such as field of view, have a certain impact on the correctness of velocity data obtained 
during image acquisition.  As the FOV was increased in this study, the spatial resolution 
of the images decreased, which has been attributed to partial volume effects [18].  As 
FOV is increased, pixel size decreases, resulting in less accurate flow data.  This change 
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resulted in data with increased deviation from true flow values, suggesting that 
minimization of FOV is important in obtaining correct flow measurements.  This is 
statistically depicted through the presentation of the Bland-Altman plots and the average 
COV calculated for each field of view.  Both the 160 and 200 mm FOV presented similar 
results, while results from the 350 mm FOV were much less accurate.  Data obtained 
using the 160 mm FOV provided slightly better results as compared to the 200 mm FOV, 
but did not significantly improve the flow data.  In this study, manual drawing techniques 
were also used and proved to be accurate with small inter- and intraobserver differences, 
specifically in the phase image map (ROI 2). The multiple-site study also confirmed the 
reproducibility of the flow measurement method.  The semiautomated vessel edge 
detection program built into the FLOW software program did not provide improved 
results.  Previous studies have shown that “in-house” automated methods improve results 
while also decreasing the time required for image analysis [18, 54, 101].  However, it is 
important to note that these methods were most likely tailored to the specific images 
acquired in each of these experiments. 
The flow characteristics used in this validation study may be classified as steady, 
laminar, and fully-developed flow, as shown in the multiple-site study. This was shown 
by the agreement in the Bland-Altman plots and the corresponding COV values, which 
were equal to less that 2% for both ROI 1 and ROI 2.  Velocity profiles obtained from 
each scan set showed the flow to be steady, and also reinforced that the flow was indeed 
laminar.  Because velocity data resulted from acquisition in only a single orthogonal 
plane, instead of all orthogonal planes, it was observed that no turbulent or complex flow 
patterns were observed throughout the simulated vessels. 
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In conclusion, the results presented here show that breath-held phase-velocity 
encoded MRI has the capability of becoming a non-invasive diagnostic tool to clinically 
investigate the hemodynamic characteristics of flow through the renal arteries.  Accurate 
data was obtained for the entire range of arterial sizes representing a healthy and diseased 
population of children and adults.  Once the spatial resolution is appropriate for a specific 
vessel size through minimization of field of view, flow data may be obtained with a high 
degree of confidence.  High-resolution scans (192 phase encodings) further improved 
measurement accuracy as compared to lower-resolution protocol previously used (96 
phase encodings).  As the number of phase encodings was increased, additional detail 
was observed in the images, causing this protocol to be more efficient at capturing 
important flow data near the simulated vessel wall.  The increase in number of phase 
encodings from 96 to 192 suggests that the number of phase encodings should be 
maximized without making the image acquisition time too long for a breath-held scan. 
These results show that when using current breath-hold MR flow-imaging technology,  it 
is feasible to capture an accurate assessment of the hemodynamic changes observed with 
the progression of ADPKD, which may further assist in understanding the pathogenesis 
of the disease.   
 Based upon this research, the parameters that were tested and provide the most 
accurate flow data for the artery sizes present in the renal arteries use a FOV of 160 mm 
× 160 mm with 192 phase encodings.  The remaining parameters that were used with 
these experiments, which provide the most correct data are as follows: repetition time 
(TR) = 24 ms, echo time (TE) = 11 ms, and flip angle = 35°.  A multi-shot echoplanar 
imaging sequence (FE-EPI) was also used during this study.   
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 Although these results indicate that clinical studies performed using the same 
protocol may result in accurate in vivo measurements, and despite efforts to mimic in vivo 
vessel conditions (biomechanical and magnetic properties, vessel size) and similar flow 
rates, the resulting recommendations should be applied to the clinical arena with caution.  
The substantial difference in preciseness of measurements observed between the low-
resolution (96 phase encodings) and high-resolution (192 phase encodings) prompted 
CRISP to change its patient protocol, accordingly, by increasing the number of phase 
encodings to 192.  This validation study was the first step in showing that velocity-
encoded MRI may be used to accurately obtain flow data in the range of vessel diameters 
observed in the renal arteries in vivo.  Further research will be performed using pulsatile 
flow characteristics in order to further improve data acquisition methods that may be 








Although numerous steps were taken in order to mimic in vivo conditions in the 
described experiments, certain improvements may be made in order to obtain more 
accurate data for the purposes of the CRISP clinical study, as well as other studies 
focusing on the renal arteries, that the present validation study supports.   
 Most importantly, for the purposes of applying phase-velocity encoded MRI to 
the renal arteries, pulsatile flow should be introduced into the experimental setup.  In vivo 
blood flow measurement is considerably more complex than the laminar flow model 
presented in this study.  Blood is non-Newtonian, and the flow profile depends on the 
time in the heart cycle and the particular vessel in question [63].  By using a pulsatile 
pump with a predetermined waveform, this issue may be addressed.  This 
recommendation is now being investigated in the Frederik Philips Magnetic Resonance 
Research Center at Emory University in Atlanta, Georgia, where the present study was 
also performed. 
 In this study, only a small sample of the effects of altering the plane angle relative 
to the vessel was observed.  Although it has been recently shown that this alteration has 
no significant effect on the flow data [18], it should be further investigated as applied to 
the renal arteries. 
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Although the use of PVA assisted in creating a vessel similar to that found in vivo, 
its use presented certain difficulties, as well.  With time, the PVA mold physically 
shrank, and a new PVA mold was required.  Although it is not extremely difficult to 
rebuild the mold, certain inconsistencies in the properties of the mold may have been 
present.  To date, no other materials exist that possess the same biomechanical and 
magnetic properties and also have an extended life cycle.  Thus, extreme care should be 
taken in creating identical phantoms for the purpose of long-term MRI validation.  
During the study, difficulty was also experienced in maintaining the position of the entry- 
and exit-length tubing inside the PVA.  Therefore, improvements should be made to the 
model to increase the friction between the PVA and the Teflon tubing by changing the 
profile of the Teflon tubing or using a bonding agent that adheres to both PVA and 
Teflon.   
In these phantom experiments, the simulated vessels were stationary, and no 
dynamic motion was involved; however, it would be tedious to create a complex phantom 
comprised of moving arteries with PVA.  It is more difficult to obtain accurate data in 
human subjects, as renal arteries exhibit motion and cross-sectional shape changes 
throughout the cardiac cycle.  Certain programming improvements should be made to 
improve the accuracy of automatic contour detection algorithms in order to decrease the 
amount of time required for post-processing, without diminishing the correctness of the 
velocity data.  The automatic detection algorithm used in this validation study was shown 
to have numerous inaccuracies; it is therefore recommended that this specific program 
should not be used for clinical purposes.  It has been discussed how other studies have 
obtained improved results using “in-house” automatic algorithms, and thus, the need for 
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an improved algorithm for renal applications certainly exists and should be applied in 
clinical investigation.  The described automatic program should also have the ability to 
correctly detect the vessel boundary when artifacts are present.  Based upon the 
discussion of the difficulty in observing certain aliasing effects in vivo, an accurate 
detection algorithm having the ability to correct for these effects would be invaluable. 
It is also important to note that in vivo studies present additional challenges in 
image acquisition and analysis.  In the renal anatomy, there is a presence of 
supernumerary arteries.  Even with improved techniques, MR sometimes fails to depict 
accessory arteries, which may be identified by conventional angiography.  With 
improved MRI technology providing increased resolution, it is hypothesized that the need 
for conventional angiography to be performed in conjunction with MR scans will become 
less important, as these smaller arteries become more visible.  However, in the meantime, 
conventional angiography should be used to observe these smaller arteries when the need 
arises. 
Although certain improvements must be made to more accurately apply phase-
velocity encoded MRI to obtain renal blood flow measurements, the current study 
provides an excellent basis for the application of phase-velocity encoded MRI to the renal 
arteries.  Further research will continue to make various adjustments to the protocol, 










































Figure A-1: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) without background 





































Figure A-2: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) with background correction 




































Figure A-3: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) without background correction at 




































Figure A-4: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) with background correction at 




































Figure A-5: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 






































Figure A-6: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 





































Figure A-7: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) without background 

































Figure A-8: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) with background correction 



































Figure A-9: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) without background correction at 




































Figure A-10: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) with background correction at 


































Figure A-11: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 




































Figure A-12: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 




































Figure A-13: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) without background 

































Figure A-14: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the magnitude image (ROI 1) with background correction 



































Figure A-15: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) without background correction at 


































Figure A-16: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 32).  This plot corresponds to the 
contour drawn in the phase image (ROI 2) with background correction at 
































Figure A-17: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data (n = 31).  This plot corresponds to the 
automatic contour drawn in the phase image (ROI 3) using the algorithm in 

































Figure A-18: Bland and Altman plot displaying the difference between the true flow  
 values and the experimental MRI data (n = 31).  This plot corresponds to the  
automatic contour drawn in the phase image (ROI 3) using the algorithm in 
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Figure A-19: Bland and Altman plot displaying the difference between methods using two 
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Figure A-20: Bland and Altman plot displaying the difference between methods using two 
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Figure A-21: Bland and Altman plot displaying the difference between methods using a 
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Figure A-22: Bland and Altman plot displaying the difference between methods using a 

































Figure A-23: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the magnitude image 


































Figure A-24: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the phase image (ROI 2) 
































Figure A-25: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the automatic contour drawn in the phase 


































Figure A-26: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the magnitude image 




































Figure A-27: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the phase image (ROI 2) 

































Figure A-28: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the automatic contour drawn in the phase 





































Figure A-29: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the magnitude image 



































Figure A-30: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
32).  This plot corresponds to the contour drawn in the phase image (ROI 2) 


























Figure A-31: Bland and Altman plot displaying the difference between the true flow 
values and the experimental MRI data using a low-resolution protocol (n = 
31).  This plot corresponds to the automatic contour drawn in the phase 
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